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Nurr1 is a transcription factor essential for the establishment, development,
terminal differentiation and maintenance of mesencephalic dopamine neurons. Nurr1 is
thought to coordinate the expression of dopamine neurotransmission genes. Nurr1-null
heterozygous (+/-) mice have reduced Nurr1 function, which impacts dopamine neuron
function in a region specific manner. Since aging can affect Nurr1 expression, we
hypothesize that aging and +/- genotype will have significant effects on dopamine
regulation and dopamine related behaviors. To test this hypothesis, regional
neurochemistry and behavioral tests of wild type (+/+) and +/- mice at 3 months of age
(young) and 12-16 months of age (aged)was performed. We also hypothesize that aging
will reduce Nurr1 expression in substantia nigra pars compacta (SNpc) and ventral
tegmental area (VTA) and also reduce expression of the genes associated with dopamine
(DA) neurotransmission that are regulated by Nurr1. To test this we isolated dopamine
neurons in SNpc and VTA using laser capture microdissection, and measured the
expression of Nurr1 and other associated DA neurotransmission genes using quantitative
PCR. Nurr1 protein levels in DA neurons in SNpc and VTA and tyrosine hydroxylase

(TH) protein levels in dopamine target regions were measured using quantitative
immunohistochemistry. A significant increase in open-field activity after stress in young
+/- mice was observed. Significant reductions in tissue dopamine levels in the ventral
striatum, including the core and shell of the nucleus accumbens were seen. In the SNpc,
there was a significant increase in D2 receptor expression and a trend toward reduced TH
expression, while in the VTA there was a significant decrease in D2 receptor expression
and TH expression due to +/- genotype. The +/- genotype caused a significantly lower
Nurr1 protein expression in the VTA which was not observed in the SNpc. Thus, it can
be concluded that Nurr1 +/- genotype has a greater impact on the mesoaccumbens system
as compared to the nigrostriatal system. The amount of Nurr1 protein expressed due to
+/- genotype was not a 50% reduction as expected due to knockout of one gene of Nurr1
suggesting compensatory mechanisms that can maintain Nurr1 protein expression closer
to the +/+ level.
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CHAPTER I
INTRODUCTION

Nurr1 is an inducible transcription factor that plays a crucial role in maintaining
the dopaminergic system of the brain and is essential for the differentiation of midbrain
dopamine neurons. An orphan member of the steroid-thyroid hormone nuclear receptor
super family, Nurr1 activates gene expression in a ligand independent manner (SaucedoCardenas et al., 1997; Wang et al., 2003). First identified from mouse brain cDNA (Law
et al., 1992) Nurr1 was localized to the chromosome 2q22-q23 (Mages et al., 1994). Also
known as NR4A2/NOT/TINUR/RNR-1/HZF-3 (Jankovic et al., 2005), it is
predominantly expressed in the central nervous system, including in the substanstia nigra
pars compacta (SNpc), ventral tegmental area (VTA) of the midbrain, olfactory bulb,
hippocampus, temporal cortex, subiculum, cerebellum, posterior hypothalamus and
habenuclear nuclei (Zetterstrom et al., 1996; Backman et al., 1999; Saucedo-Cardenas et
al., 1996). Although Nurr1 is expressed throughout the brain, its role in development and
function of dopamine neurons has received the most attention. Nurr1 is essential for the
establishment, development, differentiation and maintenance of dopaminergic neurons
(Zetterstrom et al., 1997). It is needed for both final differentiation and development of
late ventral mesencephalic dopminergic precursor cells into cells with a complete
dopaminergic phenotype (Joseph et al., 2003).
1

1.1

Nurr1 protein structure
The protein structure of Nurr1 consists of a N-terminal(amino terminal)

transactivation domain, a central DNA binding domain (DBD) and a C- terminal
(carboxy terminal) activation domain (Freedman et al., 1993; Ichinose et al.,1999; Wang
et al., 2003).The C-terminal participates in dimerization and also functions as a ligandbinding domain (LBD).The C-terminus also has a role in nuclear localization and in
transactivation or repression of gene expression. The DBD structure includes 2 zinc
fingers each with 4 cysteine residues. Several highly conserved motifs are present within
the DBD named the P-,D-,T- and A- boxes that are necessary for sequence specific DNA
binding on target genes (Eells et al., 2000). LBD of Nurr1 adopts a canonical protein fold
that resembles agonist activated LBDs of nuclear receptors (Wang et al., 2003; Maxwell
et al., 2005). According to Wang et al., there are two distinctive features in the LBD of
Nurr1that distinguish it from ligand-dependent transcription factors such as the thyroid
hormone receptor or the estrogen receptor. Firstly, Nurr1 lacks a cavity for the ligand to
occupy due to tight packing chains from several bulky hydrophobic residues and
secondly, does not have a binding site for co-activators (Wang et al., 2003).
1.2

Nurr1 gene structure
DNA sequence of the Nurr1 gene was identified using the PCR primer extension

analysis. The total length of the Nurr1 gene is 9.822 Kb and it has eight exons and seven
introns (Ichinose et al., 1999; Torii et al., 1999). It has six translated exons with
exon/intron splice sites and two 5’ untranslated exons. The exon 3 (first translated exon)
encodes the N –terminal domain and the first zinc finger of DBD. The next translated
exon encodes the second zinc finger of DBD. The third translated exon encodes the hinge
2

region while the final three translated exons encode for putative ligand binding
transactivation region, the translation stop codon, and a 3’ untranslated region,
respectively (Milbranbt, 1988; Hazel et al., 1988; Castillo et al., 1997; Ohkura et al.,
1996). The open reading frame of the Nurr1 gene is clearly defined and contains 1794
bases which encode 598 amino acids. Upstream to the initiation codon is a promoter and
transcription regulatory element (Ichinose et al., 1999; Torii et al., 1999). The 3’
untranslated region is present at the downstream region of the 8th exon. It has a total
length of 1.3kb and contains ATTTA sequence which is characteristic of short-lived
mRNAs (Paulsen et al., 1995). An exon/intron junction is present between the two zinc
fingers in the DBD (Castillo et al., 1997; Ohkura et al., 1996). Nurr1 promoter region
contains contains a NF-Κb binding motif, a Sp1 site, a glucocorticoid response element, a
cAMP response element (CRE), a CArG like element and two AP-1/c-jun sites separated
by a GC rich/Sp1-like sequence. It does not have a CCAAT or TATA elements near the
transcription start sites (Castillo et al., 1997; Torii et al., 1999; Ichinose et al., 1999). All
these response elements suggest the role of Nurr1 in immediate response pathways or
delayed early response pathways (Rivera et al., 1990). The CArG- like element has a
sequence of CC(A/T)7GG. Sp1 participates in transcription regulation and it has a
GGGCGG sequence (Maruyama et al., 1998, Torii et al., 1999). CRE has important
functions in signal transduction which is mediated by cAMP (Jankovic et al., 2005;
Murphy and Conneely, 1997).
1.3

Nurr1 in the regulation of transcription
Regulation of transcription in Nurr1 can occur via monomeric binding to the

conical DNA response element sequence AAAGGTCA called NBRE (NFGI-B response
3

element) (Paulsen et al., 1995; Zetterstrom et al., 1996). Nurr1 binding to NBRE sites in
the dopamine neurotransmission genes tyrosine hydroxylase (TH) and dopamine
transporter (DAT) are thought to function to activate the transcription of the TH and
DAT genes (Sakurada et al., 1999; Sacchetti et al., 2001). Nurr1 can also activate reporter
gene expression by binding as a homodimer or heterodimer to the inverted repeat of the
NBRE sequence when separated by six nucleotides (Philips et al., 1997). Two very
closely related proteins, Nur77 and NOR1, are two potential heterodimerization patners
of Nurr1, with whichNurr1shares about 90% homology (Milbranbt, 1988; Law et al.,
1992; Ohkura et al., 1994; Perlmann et al., 1995).
Several splice variants of Nurr1 have been reported (Ichinose et al., 1999; Xu and
Le, 2004). In mesencephalic neurons, it has 3 isoforms – hcNurr1-2, hcNurr1-3, hcNurr18. When compared to full length Nurr1, the ability of DNA binding is reduced by 36-50%
in hcNurr1-2 and hcNurr1-8, and reduced by 94% in hcNurr1-3 (Ichinose et al.,
1999).Some other Nurr1 splice variants are transcriptionally-inducible nuclear receptor
(TINUR), Nurr1a, Nurr1b, Nurr1c, Nurr2 and Nurr2c (Michelhaugh et al., 2005). The
three alternative splice variants Nurr1a, Nurr1b, and Nurr1c have truncations and/or
deletions in the C-terminus domain. These three splice variants are estimated to account
for 20-35% of Nurr1 expression. A 63amino acid deletion at the N-terminus with a
mixture of changes in the C-terminus domain is seen in TINUR, Nurr2 and Nurr2c.
Invitro transfection assays suggest that the gene activation function is attenuated by the
C-terminus deletions while the deletions of N-terminus can act as dominant negatives to
reduce function of full length Nurr1, especially Nurr2 and Nurr2c (Michelhaugh et al.,
2005).
4

1.4

In vivo expression of Nurr1
Nurr1 is expressed in a number of different tissues under basal conditions;

however, the highest levels are in the brain and pituitary gland (Law et al., 1992). During
embryonic development, Nurr1 expression is high in the brain. It peaks around
embryonic day 12-14 and declines gradually throughout development, to a steady state
level of expression in the adult (Eells et al., 2000). Around embryonic day 10.5, Nurr1 is
expressed in neurons destined to become dopaminergic in the ventral mesencephalic
flexure (Zetterstrom et al., 1996). At birth, Nurr1 is localized to the nucleus of neurons in
the olfactory bulb, subiculum, deep layers of the cerebral cortex, claustrum,
paraventricular thalamic nucleus, the dopaminergic neurons of the VTA and SNpc,
paraventricular nucleus of the hypothalamus, scattered neurons in the amygdala, motor
nucleus of the vagus, Barringtons nucleus and central gray alpha (Xiao et al., 1996;
Zetterstrom et al., 1996; Eells et al., 2000). Postnatal development changes in the
distribution of Nurr1 are very little. Expression in the areas listed above continues into
adulthood with additional expression in areas that develop postnatally including strong
expression in the granule layer of the cerebellum and scattered cells of the hippocampus
(CA1-CA3and dentate gyrus) (Xiao et al., 1996; Zetterstrom et al., 1996; Baffi et al.,
1999; Eells et al., 2000).
1.5

Function of Nurr1 in dopamine neuron development
In mice, post-mitotic neural precursor cells in the ventral midbrain begin neuronal

differentiation and express Nurr1 on 10.5 day of the embryo (Smidt et al 1997;
Zetterstrom et al, 1997). Highest expression is seen during the embryonic stage and its
expression remains in dopaminergic neurons throughout life indicating its importance in
5

maintenance of dopamine neurons (Zetterstrom et al, 1997; Lee et al 1999). During
normal development and differentiation of dopamine neurons, Nurr1 is followed closely
by TH at embryonic day 11.5 and later by DOPA decarboxylase (DDC), GTP
cyclohydrolase (GTPCH), vesicular monoamine transporter 2 (VMAT2) and dopamine
transporter (DAT), respectively (Jaeger et al., 1986). Absence of Nurr1, as seen in Nurr1
knockout mice, arrests the dopamine neuron precursor development such that these cells
fail to express many of the genes necessary for normal dopamine neuron function
including TH, VMAT2, GTPCH and DAT (Wallen et al., 1999; Zetterstrom et al., 1997;
Castillo et al., 1998; Saucedo et al., 1998; Wallen et al., 2001). Most of these arrested
dopamine neuron precursors undergo apoptosis; however, some of these precursor cells
survive until birth as they continue to express the specific dopamine neuron transcription
factor pitx3 which is essential for survival of midbrain dopaminergic neurons (Witta et
al., 2000). Mice lacking Nurr1 die at birth.
Although the role of Nurr1 in dopamine neuron development is clear, its
continued function in mature dopamine neurons remains to be determined. Conditional
deletion of Nurr1 in mature, differentiated dopamine neurons results in the loss of TH,
DAT and VMAT2. These data indicate that Nurr1 expression is needed for the continued
expression of dopamine neurotransmission genes and function of dopamine
neurotransmission. (Kadkodaei et al., 2009).
1.6

Dopamine neurotransmission
Dopamine is a catecholamine that acts as a neurotransmitter primarily in the

central nervous system (CNS). The majority of the dopamine in the CNS is located in the
nigrostriatal, mesolombic and mesocortical systems. The nigrostriatal system consists of
6

dopamine neuron cell bodies in the SNpc that innervate the striatum. The mesolimbic and
mesocortical systems consist of dopamine neuron cell bodies in the VTA that innervate
limbic areas, including the nucleus accumbens, hippocampus and amygdala, and the
prefrontal cortex, respectively. In Parkinson’s disease (PD), there is loss of dopamine
neurons in the SNpc with concomitant reduction in the nigrostriatal dopamine levels.
Altered dopamine neurotransmission in the mesocortical and mesolimbic systems is
thought to play a major role in schizophrenia (Carlsson et al., 2001, Seeman et al 1987)
where reduced mesocortical dopamine neurotransmission and elevated mesolimbic
dopamine neurotransmission have been implicated (Kienast et al., 2006).
Dopamine synthesis involves the conversion of tyrosine to DOPA by TH (Figure
2). DOPA is further converted to dopamine by the enzyme DOPA decarboxylase (DDC).
TH is the rate-limiting enzyme in dopamine synthesis, therefore TH activity can be
controlled by a number of mechanisms including regulation of expression,
phosphorylation after autoreceptor activation, end product inhibition, and the availability
of the essential cofactor tetrahydrobiopterin (BH4) (Fitzpatrick et al., 1999). BH4 is
synthesized by the conversion of GTP by the sequential action of the enzymes GTP
cyclohydrolase (GTPCH), the rate-limiting enzyme, 6-pyruvoyl-tetrahydropterin
synthase, and sepiaptin reductase (Thony et al., 2000). After synthesis, dopamine is
concentrated into synaptic vesicles by vesicular monoamine transporter 2 (VMAT2)
where upon the arrival of action potentials, it is released into the synapse (Amara et al.,
1993). Inactivation of synaptic dopamine is primarily due to active reuptake by DAT
(Jones et al., 1998; Sotnikova et al., 2005). The enzymes monoamine oxidase A and B
(MaoA and MaoB) metabolize dopamine. Extracellular dopamine either binds to
7

extracellular receptors (D1-D5) or to the dopamine autoreceptor, primarily the D2
receptor. The D2 autoreceptor regulates TH activity and dopamine release. Therefore,
parameters that affect extracellular dopamine feedback to regulate dopamine synthesis,
dopamine release and reuptake.
1.7

Function of Nurr1 in regulation of dopamine neurotransmission
Nurr1 has been implicated in the regulation of the expression of several

dopaminergic neurotransmission genes. It has been suggested that Nurr1 regulates TH,
DDC, DAT, VMAT2 and GTPCH (Sakurada et al., 1999; Hermanson et al., 2003; Kim et
al., 2003; Gil et al.. 2006). Nurr1interacts with other transcription factors and regulates
the expression of TH by binding to the NBRE sequence. In vitro data indicate that Nurr1
can regulate DAT and GTPCH from NBRE independent mechanisms (Gil et al., 2006;
Sacchetti et al., 2001). Therefore, Nurr1 can serve as a transcriptional mechanism to
coordinate the regulation of expression of many dopamine neurotransmission genes to
regulate dopamine neurotransmission. Moreover, mutations in the Nurr1 gene have been
linked to diseases such as schizophrenia, attention deficit-hyperactivitiy disorder and PD,
all diseases associated with dysfunction of dopamine neurotransmission (Buervenich et
al., 2000; Smith et al., 2005). Collectively, these data provide strong evidence for a role
of Nurr1 in regulating dopamine neurotransmission and its potential in contributing to
diseases associated with abnormal dopamine neurotransmission.
As both an immediate early gene and transcription factor, functionally, Nurr1 is
situated to link changes in dopamine neuron activity with concurrent changes in
dopamine neurotransmission. In vivo expression of Nurr1 in hippocampus and cortex
after generalized seizure and hypoxia demonstrated a rapid and transient expression of
8

Nurr1 mRNA (Crispino et al., 1998; Erdo et al., 2004). In dopamine neurons, Banon
reported that Nurr1 mRNA is reduced in cocaine addicts (Banon et al., 2002). Mice that
lacked dopamine D2 receptors have elevated Nurr1 mRNA levels in dopamine neurons
(Tseng et al., 2000). It was also reported that antipsychotic drugs that antagonize the
dopamine D2 receptor increased Nurr1 mRNA expression in midbrain dopamine neurons
(Maheux et al., 2005). According to Eells et al., changes in Nurr1 expression are
associated with elevated neuronal activity and autoreceptor activation (Eells et al., 2012).
An increase in dopamine neuron activity is seen concurrent with somatodendritic
dopamine release and stimulation of dopamine autoreceptors. Elevated dopamine neuron
activity would enhance Nurr1 expression but could also stimulate dopamine release and
autoreceptor activation and reduce Nurr1 expression. Reduced dopamine neuron activity
would reduce dopamine release and dopamine autoreceptor activation and ultimately
stimulate Nurr1 expression. Collectively, these data indicate that changes in Nurr1 levels
can influence synthesis of dopamine in mesencephalic dopaminergic neurons (Eells et al.,
2000).
1.8

Nurr1 null heterozygous mice
Nurr1 null heterozygous mice (+/-), have only one functional copy of the Nurr1

gene. Therefore, these mice represent a condition of chronic, reduced Nurr1 expression
that does not appear to alter dopamine neuron development. These mice have been used
to investigate how reduced Nurr1 levels impact dopamine neuron function in mature,
differentiated dopamine neurons. In newborn Nurr1 +/- mice, Eells et al., found reduced
expression of TH and GTPCH in the ventral midbrain (Eells et al., 2006b). Further
studies on adult mice found differential effects on the Nurr1 +/- genotype between
9

separate populations of dopamine neurons. The Nurr1 +/- genotype has been shown to
have a subtle but significant effect on dopamine neuron function in the nigrostriatal
dopamine system (Eells et al., 2006a; Zhang et al., 2012). Although the Nurr1 +/- mice
have normal numbers of nigrostriatal dopamine neurons and dopamine levels in the
striatum, these mice have reduced TH activity and an apparently reduced capacity to
maintain dopamine levels (Eells et al., 2006a). The +/- genotype, however, does not alter
nigrostriatal dopamine neurons numbers or striatal dopamine levels. In contrast, a
significant reduction in tissue dopamine levels and a greater reduction in dopamine
synthesis in the nucleus accumbens were found (Eells et al., 2002b, Eells et al., 2006a).
Additionally, reduced GTPCH mRNA expression in the VTA was also found (Eells et al.,
2006a). These data demonstrate that the mesolimbic dopamine system is more sensitive
to the effects of the Nurr1 +/- genotype.
Several studies have found that the Nurr1 +/- genotype impairs survival of
dopamine neurons. With the administration of neurotoxin MPTP, dopamine levels as well
as the number of dopamine neurons were reduced in Nurr1 +/- mice (Le et al., 1999).
Additionally, dopamine terminals in +/- mice are also more susceptible to damage by
amphetamine (Syed et al., 2005).According to Jiang et al., there was a significant
reduction in dopamine neuron numbers, striatal dopamine levels and decrease in rotorod
performance in aged +/- mice (Jiang et al., 2005). The growth of neurites is also
significantly reduced in +/- neurons (Eells et al., 2002). Adult Nurr1 +/- mice, showed
changes in locomotor activity which is thought to be related altered dopamine
neurotransmission in the nucleus accumbens (Eells et al., 2002; Backman et al., 2003).
Since Nurr1 +/-/ mice have reduced Nurr1 expression, these mice could be useful in
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determining how alterations in Nurr1 expression affect dopamine neurotransmission
(Madras et al., 2002). As Nurr1 can be affected by aging, +/- genotype may influence the
influence survival of dopamine neurons and dopamine neurotransmission in an age
dependent manner (Zhang et al., 2012).
1.9

Regional dopamine neurochemistry and dopamine associated behaviors in +/mice due to aging
Aging is a factor that produces changes in the nigrostriatal dopamine

neurotransmission, the mechanisms of which are unclear. In aged (>15 months) Nurr1+/mice, there was a reported reduction in the striatal dopamine levels, number of dopamine
neurons and a decrease in rotorod performance (Jiang et al., 2005, Zhang et al., 2012).
This model represents a potentially useful model for the study of PD and the loss of
nigrostriatal dopamine functions, as this is thought to result from a combination of
genetic predisposition with environmental insults, as aging is an important contributor to
the incidence of PD. Additionally, associations between mutations in Nurr1 and PD have
been reported . PD is characterized by the loss of dopamine neurons in the SNpc and the
subsequent loss of dopamine in the striatum (Cohen, 1983). It usually arises due to
degeneration of dopamine neurons and severe decrease in the release of straital dopamine
and dopamine transporter (Bannon and Whitty, 1997; Cruz-Muros et al., 2009; Hebert
and Gerhardt, 1999; Uhl et al., 1994). Symptoms mainly consist of movement disorders
such as, tremors, bradykinesia and muscle rigidity, cognitive deficits and ultimately
increase mortality by 2-5 times. Progressive degeneration that is seen in PD is also seen
Nurr1+/- mice. They display the same biochemical, morphological and behavioral
phenotypes with age (Imam et al., 2005; Jiang et al., 2005; Le et al., 1999a; Le et al.,
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1999b). Nurr1 +/- mice develop locomotor deficits after 15 months of age indicating a
dysfunction in dopamine neurotransmission (Jiang et al., 2005; Le et al., 1999a).
1.10 Theoretical mathematical model of a single dopaminergic synapse
Regulation of dopamine neurotransmission is controlled by a combination of a
variety of factors which include dopamine synthesis, storage, release, reuptake,
breakdown and receptor sensitivity (Eells et al., 2003). Alterations in one of these
parameters, however, frequently results in compensatory changes that maintain dopamine
homeostasis. As mentioned above, Nurr1 has been implicated in the regulation of several
dopamine neurotransmission genes including TH, DDC, DAT VMAT2 and GTPCH. TH
is the rate limiting enzyme in the biosynthesis of dopamine (Iwawaki et al., 2000). The
enzyme GTPCH is the rate limiting enzyme is the biosynthesis of BH4, which is an
essential cofactor for TH (Tatham et al., 2009) and is the primary regulator of BH4 levels.
Both TH and GTPCH have Nurr1 binding sites on their promoters to which Nurr1 is
capable of binding and inducing reporter gene expression (Eells et al., 2006; Gil et al.,
2007). Therefore, reduced Nurr1due to heterozygous-null genotype could reduce GTPCH
expression which in turn should lead to reduction in BH4 levels, which concomitantly
reduces TH activity, ultimately leading to a decrease in dopamine synthesis. DDC, DAT
and VMAT2 have also been suggested to possibly be regulated by Nurr1. Since Nurr1
may control multiple parameters that regulate dopamine neurotransmission, it is
important to have a mathematical model to predict how changes in multiple parameters
alters dopamine neurotransmission. What has not been investigated is how dopamine
neurotransmission is altered by simultaneous changes in multiple parameters of dopamine
regulation.
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The mathematical model consists of differential equations based on rate of the
reaction for the variables gtp (guanosine triphospahte), h2ntp (7,8 dihydro triphosphate),
bh4 (tetrahydrobiopterin), bh2 (dihyrobiopterin), tyr ( tyrosine), l-dopa (3,4- dihydroxy
phenylalanine), cda (cystolic dopamine), vda (vesicular dopamine), eda (extracellular
dopamine), hva (homovanillic acid), tyrpool (tyrosine pool) based on equations from
(Best et al., 2009) with the addition of GTPCH enzyme kinetics.
The rate of the reaction will be based on Michealis - Menten kinetics of the
enzymes involved in any of the following standard forms.
For unidirectional reactions with one substrate

(1.1)
For Unidirectional reactions with 2 substrates

(1.2)
For bidirectional reactions with 2 substrates and 2 products
(1.3)
The differential equations for all the reactions in the diagram are as follows
(1.4)
(1.5)
,
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–

,

(1.6)

bh2, NADPH, bh4, NADP
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(1.12)

.

.

.

(1.8)

.

(1.13)
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(1.15)

The substrates are in lower case, enzyme names and velocities are in upper case
so that it is easy to distinguish between all of them. For example,
bh2, NADPH, bh4, NADP is the velocity of dihydrobiopterin reductase and it
depends on the concentration of bh2 and bh4 as well NADPH and NADP as it reduces
bh4 to bh2. All the above mentioned equations can be solved using matlab.
BH4 is an essential co-factor for TH. GTP is converted to 7, 8 dihydroneopterin
triphosphate (H2NTP) by GTPCH 1.
PTPS
SR
GTP GTPCH
 H 2 NTP 
 PPH 4 
BH 4

H2NTP is then converted to 6 pyruvoyltetrahydrobiopterin (PPH4) by
pyruvoyltetrahydrobiopterin synthase (PTPS), which is subsequently converted to
tetrahydrobiopterin by sepiaterin reductase (SR). Activity of GTPCH regulates the
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intracellular concentration of BH4. The intracellular concentrations of bh4 in turn affect
the activity of TH.
TH
Tyrosine  bh4  cda  eda 
L  DOPA  bh2

Tyrosine, with bh4, is converted to l-dopa. The velocity of the reaction, VTH depends on
the concentration tyrosine (tyr), bh4, cda and vda via DAT. Sometimes TH is inhibited
by tyrosine itself, this is called substrate inhibition. Cda inhibits the activity of TH by
competing with bh4. Binding of eda to DAT also inhibits TH. Higher eda means that
dopamine autoreceptors are more stimulated which decreases TH activity and hence less
dopamine is released.
Here we also take into consideration the tyrosine that enters the brain through the blood
brain barrier. Assuming the kinetics to be that of a neutral amino acid, we calculate the
velocity a VTYRin (btyr). A single variable, tyrpool is used to represent all other sources
of tyrosine.

assuming that tyrosine is in a linear exchange with the tyrpool
AADC
l  dopa 
 cda

cda vmat

 vda
fire ( t )
vda 
 eda

l-dopa is thereby converted to cytosolic DA (cda) by DDC. Cda is transported into
vesicle by VMAT and vesicular dopamine (vda) is released into the extracellular space
of the synaptic cleft based on the rate of firing of the dopamine neuron. The extracellular
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dopamine (eda) is taken back into the pre-synaptic terminal by DAT and dopamine
autoreceptors exhibits feedback inhibition on TH. The term fire (t) vda means fire is a
function of time. cda is catabolised by monoamine oxidase (mao) and aldehyde
dehydrogenase to dihydrophenylacetic acid (dopac). Dopac, then is transported out of
the neuron and is converted to homovanillic acid (HVA) by catecholamine methyl
transferase .

cda mao

 dopac comt

 HVA
We assume that the removal of cda follows first order kinetics and is a linear
process, therefore the term

. Extracelular dopamine (eda) is also catabolised first

by COMT and then MAO, denoted by the term

for removal of hva from the

system. The term krem (eda) represents the removal of eda by diffusion out of the
striatum or uptake by glial cells and blood. Based on the concentration of GTPCH, TH
and DAT, we will be able to theoretically calculate the amount of dopamine synthesized
and released. This will allow us to predict the result on extracellular dopamine as a result
of changes in expression or function of these parameters.
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Figure 1.1

Gene structure of Nurr1 nuclear receptor (A) and a diagram of its protein
structural domains (B).

Exons regions are numbered and shown with boxes and introns by lines. The hatched
regions indicate the exon coding portions and are matched with the corresponding protein
domain. Numbers above the introns indicate their length in bases. Numbers beneath the
coding exons indicate their length in bases from the start codon (beginning at the third
nucleotide in the first coding exon) to the stop codon. The 3 structural domains of the
protein are shown in (B) with the relative positions of the Zinc fingers and P-box, D-box,
T- box and A-box in the DNA binding domain (DBD).Abbreviations: Ct, carboxy
carboxy terminal; LBD, ligand-binding domain ; Nt , amino terminal (Eells et al., 2000).
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Figure 1.2

The components and interactions of the dopaminergic synapse.

Abbreviations: AC, adenylyl cyclase; BH4, tetrahydrobiopterin; COMT, catechol-Omethyltransferase; DA, dopamine; DAT, dopamine transporter; D1R, dopamine D1
receptor; D2L, long isoform of dopamine D2 receptor; D2S, short isoform of dopamine
D2 receptor; DDC, dihydroxy-L-phenylalamine decarboxylase; DOPA, dihydroxy-Lphenylalamine; DOPAC, 3,4-dihydroxyphenylacetic acid; GTPCH, GTP cyclohydrolase
I; HVA, homovanillic acid; MAO, monoamine oxidase; TH, tyrosine hydroxylase;
VMAT2, vescicular monoamine transporter 2 (Eells 2003).
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Figure 1.3

The mesencephalic dopamine system.

It is divided into the mesolimbic/mesocortical dopamine system, which consists of
neurons in the ventral tegmental area (A10) and retrorubral nucleus (A8) innervating the
mesolimbic areas (NucA, nucleus accumbens; Am, amygdala; PirCTX, piriform cortex;
EntoCTX; entorhinal cortex) and mesocortical areas (PreCTX, prefrontal cortex) (A) and
the and the nigrostriatal dopamine system, which consists of neurons in the substantia
nigra pars compacta (A9) innervating the striatum.
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CHAPTER II
EFFECTOF AGING AND NURR1 +/- GENOTYPE ON REGIONAL DOPAMINE
NEUROCHEMISTRY AND DOPAMINE ASSOCIATED BEHAVIORS

2.1

Abstract
The transcription factor Nurr1 is essential for dopamine neuron differentiation and

is important in maintaining dopamine synthesis and neurotransmission in the adult.
Reduced Nurr1 function due to the Nurr1-null heterozygous genotype (+/-), impacts
dopamine neuron function in a region specific manner, resulting in a decrease in
dopamine synthesis in the dorsal and ventral striatum and a decrease in tissue dopamine
levels in the ventral striatum. Additionally, maintenance of tissue dopamine levels in the
dorsal striatum and survival of nigrostriatal dopamine neurons with aging (>15 months)
or after various toxicant treatments are impaired. To further investigate the effects of
aging and the Nurr1-null heterozygous genotype, we measured regional tissue dopamine
levels in the dorsal striatum, body weight, open field activity and rota-rod performance in
young (3-5 months) and aged (15-17 months) wild-type +/+ and +/- mice. Behavioral
tests revealed no significant differences in rota-rod performance or basal open field
activity as a result of aging or genotype. The +/- mice did show a significant increase in
open field activity after 3 min of restraint stress. No differences in tissue dopamine levels
were found in the dorsal striatum. However, there were significant reductions in tissue
dopamine levels in the ventral striatum, which was separated into the nucleus accumbens
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core and shell, in the aged +/- mice. These data indicate that the mesoaccumbens system
is more susceptible to the combination of aging and the +/- genotype than the nigrostriatal
system. Additionally, the effects of aging and the +/- genotype may be dependent on
genetic background or housing conditions. As Nurr1 mutations have been implicated in a
number of diseases associated with dopamine neurotransmission, further data is needed to
understand why and how Nurr1 can have differential functions across different dopamine
neuron populations in aging.
2.2

Introduction
Dopamine neurotransmission has been implicated in a number of pathological

conditions including Parkinson’s disease, schizophrenia, attention deficit hyperactivity
disorder and addiction (Steece-Collier et al., 2002; Solanto, 2002; Merims and Giladi,
2008; Howes and Kapur, 2009). Nurr1 (NR4A2) is a nuclear receptor/transcription factor
that is essential for proper development of mesencephalic dopamine neurons as
homozygous disruption of Nurr1 stops differentiation of these neurons (Zetterstrom et al.,
1997; Castillo et al., 1998; Saucedo- Cardenas et al., 1998). Mutation analysis has
implicated a role for Nurr1 in some of these pathological conditions. Mutations in Nurr1
have been linked to Parkinson’s disease (Xu et al., 2002; Hattori et al., 2003; Le et al.,
2003; Grimes et al., 2006) and Nurr1 is reduced in patients with Parkinson’s disease and
correlates with the loss of tyrosine hydroxylase immunoreactivity (Chu et al., 2002;
Jankovic et al.,2005; Chu et al., 2006). Two different missense mutations in exon 3 of
Nurr1 were identified in 3 patients with either schizophrenia or bipolar disorder
(Buervenich et al., 2000).
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Nurr1 has been implicated as a transcription factor that regulates the expression of
several dopamine neurotransmission genes including tyrosine hydroxylase, dopamine
transporter, vesicular monoamine transporter and GTP cyclohydrolase (Jankovic et al.,
2005; Iwawaki et al., 2000; Sacchetti et al., 2001; Hermanson et al., 2003; Eells et al.,
2006a; Gil et al., 2007; Kadkhodaei et al., 2009). With the potential to alter multiple
parameters regulating dopamine neurotransmission, the effects of Nurr1 on dopamine
neurotransmission are complex. The role of Nurr1 in the regulation of dopamine
neurotransmission in adult animals is mostly based on experiments in the Nurr1-null
heterozygous mice (+/-). The Nurr1 +/- genotype has been shown to have a subtle but
significant effect on dopamine neuron function in the nigrostriatal dopamine system
(Eells et al., 2006a; Zhang et al., 2011). Although the Nurr1 +/- mice have normal
numbers of nigrostriatal dopamine neurons and dopamine levels in the striatum, these
mice have reduced tyrosine hydroxylase activity and an apparently reduced capacity to
maintain dopamine levels (Eells et al., 2006a). Additionally, reduced Nurr1 function in
these mice increases the susceptibility of nigrostriatal dopamine neurons to the
neurotoxins MPTP, amphetamine and rotenone and the irreversible proteasome inhibitor
lactacystin (Le et al., 1999; Imam et al., 2005; Pan et al., 2008). Similarly, when
dopamine neurons from +/+ and +/- newborn pups were grown in culture, survival and
neurite growth in dopamine neurons from +/- mice was significantly reduced (Eells et al.,
2002a).
Although the nigrostriatal dopamine system is impacted by the Nurr1 +/genotype, the mesoaccumbens dopamine system, dopamine neurons in the ventral
tegmental area that innervate the ventral striatum consisting of the nucleus accumbens
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core and shell (NAC and NAS), respectively, appears to be more susceptible to the
effects of the +/- genotype. Significant reductions in tissue dopamine levels in the nucleus
accumbens and GTP cyclohydrolase mRNA expression in the ventral tegmental area
have been reported (Eells et al., 2006a; Eells et al., 2002b; Eells et al., 2006b). No
differences in these parameters were observed in the nigrostriatal system (Eells et al.,
2006a; Eells et al., 2002b; Eells et al., 2006b). Additionally, a significant elevation in
synaptic dopamine levels, as measured by microdialysis was found in the shell of the
nucleus accumbens of Nurr1 +/- mice that was not observed in the striatum (Moore et al.,
2008).
Previous studies have found that aging is an important parameter that affects both
dopamine neurotransmission and Nurr1 levels. Aging produces various changes in the
function of the nigrostriatal dopamine neurotransmission; however, the mechanisms of
these changes are unclear. A number of changes in dopamine function have been reported
in the striatum. One of the most consistent is the decrease in D2 receptor expression in
the striatum (Umegaki et al., 2008). In the Nurr1 +/- mice, reductions in striatal dopamine
levels, reduced numbers of dopamine neurons and a decrease in rota-rod performance in
the aged (>9 months) +/- mice have been reported (Jiang et al., 2005; Zhang et al., 2011).
Based on these data, the Nurr1 +/- mice may represent a potentially useful model of
Parkinson’s disease because it combines a genetic mutation that increases the
susceptibility of the nigrostriatal dopamine neurons to an environmental stressor such as
aging which mimic parameters thought to contribute to Parkinson’s disease. These data
suggest that aging can influence Nurr1 expression and also produces various changes in
the function of the nigrostriatal dopamine neurotransmission. It is unclear, however, how
23

aging could also affect other dopamine systems particularly the mesoaccumbens system
which could provide insight into the differences in regulation between these neuron
populations.
These experiments were initiated to further examine the effects of aging in the
Nurr1 +/- mice on both the nigrostriatal and mesoaccumbens dopamine systems.
Furthermore, these studies were initiated to determine if aging has similar or distinct
effects on the mesoaccumbens and nigrostriatal dopamine neurons associated with aging.
The data indicate that aging and the +/- genotype can produce subtle effects on
nigrostriatal dopamine neurotransmission. However, the regulation of tissue dopamine
levels in the ventral striatum is the most susceptible to the combination of aging and the
+/- genotype.
2.3
2.3.1

Materials and methods
Animals
The Nurr1-null heterozygous mice used for this study were obtained from a

colony bred at Mississippi State University. These mice were originally produced in the
laboratory of Dr. Vera Nikodem at the National Institute for Diabetes and Digestive and
Kidney Diseases (Castillo et al., 1998). Mice were genotyped as previously described by
Castillo et al., 1998 to distinguish +/- and +/+ mice using tail DNA by PCR. Litters were
chosen at random for either young or aged mice. The mice were weaned at 19-21 days of
age and housed in groups of 3-5/cage. Mice were housed in cages with steel grid lids and
all cages were located in the same room. All procedures were performed in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals,
and study protocols were approved by the Institutional Animal Care and Use Committee
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at Mississippi State University. All animals used in this project were housed in the
AAALAC accredited facilities of the College of Veterinary Medicine, Mississippi State
University. The individual room temperatures were maintained between 18-22°C with
food and water ad libitum. Care of the mice was overseen by a laboratory animal
veterinarian. Adult male +/- and +/+ mice, 3 months old and >15 months old e mice were
used to study the behavior neurochemistry measurements of Nurr1 +/- mice.
2.3.2

Behavior
To assess motor coordination of these Nurr1+/- mice, we tested their rotorod

performance and open field activity.
2.3.2.1

Rotorod Performance
Mice were tested on 4 station rotorod set up (Med associates, St. Albans, VT)

which increases its speed from 3-30 rpm. Each mouse underwent 2 rounds of training
with a 4 min rest in between. During training, the mice were placed on rotating rod for 2
min. If the mouse fell off during this time it was placed back on the treadmill so that all
mice received the same amount of training time. After the training, 3 test trials were done
on each mouse. In the test trials, the mice were not put back on the rod when they feel
off. The time spent and the speed reached by each mouse was recorded and compared
between +/+ and +/- young and aged mice. Additionally, the weight of the each mouse
was recorded at the end of the rotorod testing.
2.3.2.2

Open Field activity
This is done to assess the normal and stress induced locomotor activity of

themice. The mice were placed in an open field chamber, which consisted of 25cm×25cm
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plexiglass enclosure with a video camera mounted above. This whole setup is connected
to a computer and the total distance travelled by the mice was measured and recorded as a
video by Limelight Software. Mice were tested during the light cycle between 12:00hrs
and 14:00 hrs beginning at approximately the same time with one session each day. The
basal activity of the each mouse was recorded for the initial period of 45 min in the open
field chamber. After this, mice were placed in a Broome rodent restrainer for 3 min to
produce restraint stress. The mice were then placed back in the open field chamber to
monitor their locomotor activity after the stress condition. The total distance travelled by
these under stress and basal conditions was compared across genotype and age. The
number of mice used for behavior analysis included 22 +/+ young, 37 +/- young, 7 +/+
aged, and 8 +/- aged.
2.3.3

Tissue Dissection
One week after the open field test, the mice were euthanized with CO2

asphyxiation. The brains were removed immediately, cut into forebrain and mid brain
pieces and frozen on dry ice and then stored at -80°C.
2.3.4

Dopamine Neurochemistry
The left piece of frozen forebrain tissue was mounted in a custom made tissue

slicer with O.C.T compound (Sakura Finetek, Torrance, CA) and 600-800 μm thick
frozen sections were cut and mounted on glass slides. Micropunches of the dorsal
striatum were isolated using a blunt 20 gauge needle. Micropunches of the nucleus
accumbens core was taken with a 22 gauge blunt needle then the remaining nucleus
accumbens shell was dissected using an 18 gauge blunt needle. A micropunch of the
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prefrontal cortex was also taken with a blunt 20 gauge needle. Approximate locations of
these dissected regions are shown on sections treated with tyrosine hydroxylase
immunohistochemistry in Figure 2.1.
Micropunches were used for determination of dopamine and metabolite levels
using high performance liquid chromatography (HPLC) and electrochemical detection.
Micropunches were sonicated in 0.1 M perchloric acid and 100 μM EDTA at 4° C then
cleared by two successive centrifugations at 10,000 g. The cleared supernatant was
injected into a HPLC system consisting of a Waters 2695 Separation module. The
remaining pellet was solubilized in 1M HCl and total protein was determined using BCA
according to manufactures instructions. The number of mice used for tissue dopamine
levels consisted of 7 +/+ young, 10 +/- young, 7 +/+ aged, and 8 +/- aged. Tissue
extractions (10-20 μl) were injected into a HPLC system consisting of a Waters 2695
Separation module, a SupleCosil LC-18-DB column with the Waters
2465electrochemical detector set at 20 nA and an Ec=+0.67V using a mobile phase of
100 mM phosphate, 17.5% methanol, 25 μM EDTA, 1 mM octyl sodium sulfate at pH
3.65. The quantity of each compound was determined based on the response of a known
amount of standards of dopamine, DOPAC and HVA (Sigma Aldrich, St. Louis, MO)
and are reported as pg in the dialysate.
2.3.5

Statistical Analysis
The data obtained were statistically analysed using ANOVA with fishers PLSD

post-hoc comparison using Statview software.
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2.4
2.4.1

Results
Roto-rod performance and open field activity in young and aged, +/+ and
+/- mice
Behavioral analysis was carried out on the young and aged, +/+ and +/- mice. The

behavioral test consisted of rota-rod performance, open field activity in a novel
environment and after 3 min of restraint stress. The weight of each mouse was also
recorded. There was a positive correlation between age and weight and a negative
correlation between rota-rod performance and weight. Aging significantly increased
weight, although there was no significant difference across genotype (Fig. 2.2A). In the
rota-rod test, aging significantly reduced rota-rod performance in both +/+ and +/- mice
(Fig. 2.2B). No significant differences were observed on rota-rod performance due to
genotype. There was a trend of reduced performance in the aged +/+ mice but much of
this was the result of two animals with very low performance (3.7 and 5.7 s). In open
field activity, there were no significant differences in total distance traveled in the basal
condition (Fig. 2.2C). The young +/- mice, however, were significantly more active after
the restraint stress than the young +/+ mice (Fig. 2.2D). In the aged mice, there was no
genotype difference in stress induced activity although there were fewer aged mice tested
than young mice.
2.4.2

Tissue dopamine levels in the ventral striatum are attenuated by aging in
the +/- mice
Tissue dopamine and metabolite levels were measured in micropunches from the

dorsal striatum, the ventral striatum separated into the NAC and NAS, and the prefrontal
cortex across young and aged +/+ and +/- mice. Within the dorsal striatum, there were no
significant differences in tissue dopamine levels observed due to the +/- genotype or
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aging (F3, 28=2.692,p=0.0660) (Fig. 2.3A). In fact, there was a trend toward a reduction
in tissue dopamine levels from the dorsal striatum in the aged +/+ mice as compared to
young +/+ mice and aged +/- mice (Fig.2.3A). There were no significant differences in
DOPAC or HVA levels or dopamine turnover in the dorsal striatum (Table 2.1). The
ventral striatum, consisting of the NAS and the NAC, showed a different pattern of
changes in dopamine neurochemistry as compared to the dorsal striatum. Specifically,
there was a significant reduction in tissue dopamine levels in the aged +/- mice as
compared to both the young +/- mice and the aged +/+ mice similarly in both the NAS
(F3, 28=2.949, p=0.049) and NAC (F3,28=4.05, p=0.0165) (Fig. 2.3B and 2.3C). Within
the NAC, there was also a significant reduction in DOPAC levels in the aged +/- mice
(F3,28=4.092, p=0.0162) (Table 2.1). No differences in HVA levels were found across
groups in the either the NAC or NAS. Calculations of dopamine turnover are shown in
Table 2.1 that consists of the average of the ratio of dopamine to DOPAC and dopamine
to HVA. There were significant elevations in dopamine turnover (dopamine/HVA) in the
aged +/- mice in the NAS and NAC. No differences in dopamine neurochemistry were
observed in the prefrontal cortex across age or genotype.
2.5

Discussion
Currently, animal models that reproduce all of the neuropathology and

neurodegeneration found in Parkinson’s disease are lacking. The most widely used
models consist of the use of various toxins to kill or damage dopamine neurons. Because
of the important contribution of aging in the etiology of Parkinson’s disease as well as
links to genetics, a more ideal model would consist of a genetic mutation that, when
combined with aging, produces progressive deficits in dopamine levels and
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neurodegeneration of nigrostriatal dopamine neurons. Previous reports using aged Nurr1
+/- mice have described significant effects in the nigrostriatal dopamine system. Aging
(as early as 9-12 months) in the Nurr1 +/- mice resulted in a significant reduction in
dopamine levels in the striatum, impaired performance on the rota-rod, and reduced
numbers of dopamine neurons in the substantia nigra pars compacta in the aged +/- mice
(Jiang et al., 2005; Zhang et al., 2011). Because of the potential importance of this model,
we began further investigations into how aging alters dopamine transmission in Nurr1 +/mice but also included other mesencephalic dopaminergic systems.
In contrast to previous reports, the current data found no difference in tissue
dopamine levels in the dorsal striatum of aged +/- mice (Fig.2.3). However, significant
reductions in tissue dopamine levels in the ventral striatum, including the NAS and NAC,
resulted from the combination of aging and the +/- genotype. Potential reasons for these
differences could be explained by either the background strain of mice or construct used.
Three independently derived strains of Nurr1 knockout mice were produced by the
laboratories of Dr.Conneely (Saucedo-Cardenas et al., 1998), Dr. Perlmann (Zetterstrom
et al., 1997) and Dr. Nikodem (Castillo et al., 1998) and used between the various
studies. Comparisons between parameters used to create these different lines have been
reviewed previously (Eells et al., 2000). Backman, using the Perlmann derived mice,
reported no differences in tissue dopamine levels using micropunches from the striatum
or number of dopamine neurons in the substantia nigra pars compacta in Nurr1 +/- mice
12-15 months of age (Backman et al., 2003). In fact, these authors found higher, but not
significantly higher, dopamine and DOPAC levels in the +/- mice. These results more
closely resemble the data in this current report using the Nikodem line of Nurr1 +/- mice.
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Jiang et al., and Zhang et al., both found significant reductions in dopamine neuron
numbers in the substantia nigra and reduced tissue dopamine in the striatum at 9-12
months (Zhang et al., 2011) and 15-19 months (Jiang et al., 2005) of age in the Nurr1 +/mice using the Conneely line of Nurr1 +/- mice. Interestingly, Le et al., (Le et al., 1999)
reported no differences in tissue dopamine levels in the striatum or the number of
nigrostriatal dopamine neurons in aged (13-14 month) Nurr1 +/- mice, also using the
Conneely line. This suggests that the breeding conditions or background strain could
have an impact on the penetrance or expressivity of the Nurr1 +/- mutation to impact
survival of dopamine neurons with aging. Although genes have been identified that can
cause Parkinson’s disease, such as SNCA, LRRK2, parkin, PINK1, and DJ-1 (reviewed
in Greggio et al., 2011), most cases have a relatively small genetic component with low
concordance rates among monozygotic twins (Tanner et al., 1999; Wirdefeldt etal., 2004;
Wirdefeldt et al., 2011). Therefore, understanding the genetic context necessary for the
Nurr1 +/- genotype to produce a loss of dopamine neurons and tissue dopamine in the
striatum could be very informative.
Differences in housing condition or other aspects of the environment may impact
the role of Nurr1 in regulating dopamine neuron function and survival. Nurr1, as an
immediate early gene, is sensitive to stress, can be induced by various drugs, and could
be sensitive to various housing conditions (Eells et al., 2006b; Moore et al., 2008;
Maheux et al., 2005; Rojas et al., 2010). Previous data demonstrated that isolation had a
significant effect on tissue dopamine levels in the dorsal striatum and that isolation could
have a differential effect, depending on the +/- genotype, on dopamine neurotransmission
in the NAS (Eells et al., 2006b; Moore et al., 2008). In the current study, all mice were
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raised in groups of 3-5, none were isolated. Differences across laboratories in how the
mice were reared, such as when they are weaned or types of caging could also have an
effect on the results. Any factor that produces different levels of stressors has the
potential to impact Nurr1 expression and dopamine neuron function.
Elevated stress induced open-field activity has been consistently reported in
theNurr1 +/- mice. This result was first reported in by Eells et al. and replicated by others
and appears to be the most robust behavioral finding in these mice regardless of the
derived strain (Eells et al., 2002b; Backman et al., 2003; Werme et al., 2003; Jiang et al.,
2005). To produce a stress response, we restrained the mice for 3 min prior to placing
them back in the open-field. The young +/- mice showed a significant increase in openfield activity after stress. We had previously assigned the stress induced increase in
activity to differences in mesoaccumbens dopamine neurotransmission.
However, based on the present study, this difference is apparent in the absence of
any detected difference in dopamine levels in the nucleus accumbens of the +/- mice.
Although alterations in the mesoaccumbens neurotransmission could account for
differences in open-field activity in the +/-, the precise mechanism that mediates the
difference in the stress induced open-field activity in the +/- mice is unclear.
Although the Nurr1 +/- genotype has been found to have significant effects on the
nigrostriatal dopamine system, effects on the mesoaccumbens dopamine system appear to
be more prominent although less well characterized. Significant reductions in tissue
dopamine levels were reported in the +/- mice in the nucleus accumbens without
significant effects in the striatum (Eells et al., 2002b; Eells et al., 2006b). In the current
data, no significant differences in dopamine levels in the ventral striatum of young +/32

mice were observed, either in the NAS or NAC. Differences in dissection technique
(dorsal and ventral striatum isolation from fresh tissue versus micropunches in frozen
sections) and electrochemical detection methods (extraction versus direct measurement)
could account for some differences. Aging, however, may be an important variable in
producing the deficit in dopamine in the ventral striatum.
Additionally, breeding may impact the effect of the +/- mutation as mentioned
above. Further studies with direct comparisons at different ages will be important to
differentiate effects here. Additionally, the effect aging has on Nurr1 levels in dopamine
neurons in the ventral tegmental area have not been investigated. The striatum consists of
medium spiny neurons that primarily receive synaptic input from the pyramidal neurons
in the cerebral cortex along with dopamine innervations from the mesencephalon.
Dopamine innervation to the dorsal striatum consists of dopamine neurons in the
substantia nigra pars compacta. The ventral striatum, however, receives dopamine
innervations primarily from the ventral tegmental area, mostly the NAS. Dopamine
neurons inthe medial substantia nigra pars compacta and lateral ventral tegmental area
innevate the NAC (Humphries and Prescott, 2009). Studies have found differences in
electrophysiology and gene expression between nigrostriatal dopamine neurons in the
substantia nigra pars compacta and mesoaccumbens dopamine neurons in the ventral
tegmental area (Greene et al., 2005; DiSalvio et al., 2010). Differences in autoreceptor
function and/or dopamine uptake between these areas could underlie the observed effects
of aging and the +/- genotype between the dorsal and ventral striatum. Currently, how
Nurr1 can differentially affect these separate dopamine systems has not been elucidated.
It is unclear whether these differences are due to differences in the neurons innervating
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these areas or whether there are local effects across the dorsal and ventral striatum that
result in the differences in tissue dopamine levels observed.
2.6

Conclusion
The Nurr1 +/- genotype appears to be an important regulator of tissue dopamine

as it relates to the mesoaccumbens dopamine system and that aging is an important
variable in how Nurr1 regulates dopamine levels. As for the nigrostriatal dopamine
system, there are, apparently, other factors that influence whether dopamine neuron
numbers and tissue dopamine levels are affected by the +/- genotype. Understanding the
interaction between how the environment or genetic background can interact with the
Nurr1 +/- genotype could have important implications for understanding the genetic
complexity of Parkinson’s disease. The interaction between aging and the +/- genotype
suggest that aging is an important factor for the regulation of Nurr1 and the function of
the mesoaccumbens dopamine system, which could have implications to other
neurological problems such as psychosis, addiction or attention deficit hyperactivity
disorder in which the mesoaccumbens dopamine neurotransmission has a prominent role.
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Figure 2.1

Approximations of the regions and size of tissue dissected in thick frozen
section and used for dopamine neurochemistry.

Sections are approximately 1.70 mm (A) and 1.00 mm (B) rostral to Bregma. Sections
were modified from Paxinos and Franklin (2000).
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Figure 2.2

Rotorod performance and Open field activity.

Body weight (A), rota-rod performance (B) and total distance traveled in an open field
activity field under basal conditions (C) and after 3 min of restraint stress (D) were
measured in young and aged wild-type (+/+) and Nurr1-null heterozygous (+/-) mice. No
genotype differences in body weight were found, although aging significantly increased
with body weight.Rota-rod performance was also significantly impaired with aging. The
aged +/+ mice showed a trend toward impaired rota-rod performance, but was not
significantly different compared to the aged +/- mice (C). No significant differences were
found in basal open field activity, however, +/- mice were significantly more active after
3 min of restraint stress. Bars represent mean ± S.E.M. Brackets represent significant
difference between treatments based on ANOVA with Fisher’s PLSD post-hoc
comparison with p<0.05.
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Figure 2.3

Tissue dopamine levels.

Tissue dopamine levels were measured in tissue punches from the dorsal striatum (A),
nucleus accumbens shell (B), and nucleus accumbens core (C) across young and aged
wildtype (+/+) and Nurr1-null heterozygous (+/-) mice. There was a significant reduction
in dopamine in the nucleus accumbens shell and core in the aged +/- mice. Bar graphs
represent mean ± S.E.M. Brackets represent significant difference between treatments
based on ANOVA with Fisher’s PLSD post-hoc comparison with p<0.05.
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Table 2.1

Regional dopamine metabolite levels and dopamine turnover
Young +/+

Young +/-

Aged +/+

Aged +/-

DOPAC

2.28 ± 0.26

2.61± 0.31

1.98 ± 0.29

2.45 ± 0.62

HVA

64.30 ± 3.43

50.16 ± 5.26

49.58 ± 4.10

53.11 ± 2.31

DOPAC/Dopamine 0.00236 ± 0.00026

0.00296 ± 0.00040

0.00361 ± 0.00110

0.00297 ± 0.00057

HVA/Dopamine

0.067 ± 0.004

0.057 ± 0.005

0.077 ± 0.006

0.068 ± 0.007

2.60 ± 0.83

2.94 ± 0.50

2.84 ± 0.47

3.67 ± 0.44

32.76 ± 1.83

29.10 ± 1.61

31.37 ± 3.38

28.27 ± 2.92

0.00543 ± 0.00127

0.00553 ± 0.00070

0.00579 ± 0.00205

0.01077 ± 0.00306

0.31 ±0.044

0.25 ± 0.029

0.28 ± 0.018

0.36 ± 0.034#

Nucleus Accumbens
Core
DOPAC
3.67 ± 1.03

7.54 ± 2.39

1.03 ± 0.96

1.07 ± 0.70#

HVA

108.41 ± 26.53

82.29 ± 13.16

82.65 ± 7.97

DOPAC/Dopamine 0.00399 ± 0.00118

0.00474 ± 0.00125

0.00389 ± 0.00130

0.000366 ± 0.00099

HVA/Dopamine

0.15 ± 0.02

0.12 ± 0.01

0.14 ± 0.01*

0.23 ± 0.02*, #

Dopamine

5.51 ± 1.20

4.20 ± 0.850

6.31 ± 1.074

4.85 ± 1.019

DOPAC

0.993 ± 0.141

0.898 ± 0.116

0.766 ± 0.107

0.901 ± 0.059

HVA

13.07 ± 1.477

11.23 ± 1.774

10.57 ± 1.542

9.00 ± 1.116

DOPAC/Dopamine 0.214 ± 0.072

0.282 ± 0.073

0.112 ± 0.015

0.197 ± 0.027

HVA/Dopamine

2.816 ± 0.452

1.484 ± 0.154

1.818 ± 0.290

Striatum

Nucleus Accumbens
Shell
DOPAC
HVA
DOPAC/Dopamine
HVA/Dopamine

99.11 ± 6.44

Prefrontal Cortex

3.175 ± 0.985

*Genotype difference, #Age difference after ANOVA and post-hoc comparison. p <0.05.
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CHAPTER III
REGIONAL EXPRESSION OF NURR1 PROTEIN IN WILD TYPE AND
HETEROZYGOUS NURR1 MICE USING QUANTITATIVE
IMMUNOHISTOCHEMISTRY

3.1

Abstract
In addition to being expressed in the mesencephalic dopaminergic neurons, the

orphan nuclear receptor Nurr1 is also expressed in the limbic and cortical areas of the
brain. Currently, the regional expression or quantification of Nurr1 protein expression has
been investigated. To study the expression of Nurr1 proteins in different regions of the
brain, we used quantitative immunohistochemistry (Q-IHC). This method combines
immunohistochemistry and the readily available computer software Adobe Photoshop
and Matlab to get a quantified numerical value for a Nurr1 immunoreactive nucleus
based on chromogen intensity. Based on chromogen intensity, neurons in the primary
cortex had the highest relative Nurr1 expression (100%) followed closely by the deep
temporal cortex (85%) and subiculum (76%). Lower Nurr1 levels were found in the
dopamine neurons in the substantia nigra and ventral tegemental area (39%) followed by
CA1 region (25%) and CA3 region (19%) of the hippocampus. We also studied the
differences in the expression of Nurr1 in the above mentioned regions in both Nurr1-null
heterozygous (+/-) and wild type (+/+) mice. Based on chromogen intensity calculated
using Matlab, the regional differences in Nurr1 protein expression in the +/- as compared
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to +/+ were 27% reduction in the primary cortex, 49% reduction in the deep temporal
cortex, 25% reduction in the subicullum, 33% reduction in in substantia nigra and 22%
reduction in ventral tegemental area followed by 21% reduction in CA1 region of the
hippocampus. These data demonstrate the capability to quantify Nurr1 protein expression
and suggest that potential regional compensatory mechanisms can account for a loss of a
Nurr1 allele.
3.2

Introduction
The orphan nuclear receptor Nurr1, functions in maintaining the dopaminergic

system of the brain and is linked to the pathogenesis of diseases affecting the dopamine
system (Buervenich et al., 2003). Nurr1 is needed for the differentiation and development
of mesencephalic precursor cells into dopaminergic phenotype and help in motor function
(Wallen-Mackenzie et al., 2003). Mice lacking this transcription factor fail to express
midbrain dopamine neurons (Saucedo-Cardenas and Conneely, 1996, Zetterstrom et al.,
1997). Nurr1 is expressed by dopamine neuron precursors on E10.5 (Smidt et al., 1997;
Zetterstrom et al., 1997). The dopamine neuron precursors start terminal differentiation at
E11.5 and begin to express tyrosine hydroxyase (TH), DOPA decarboxylase (DDC),
vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) which are
essential enzymes for the synthesis of dopamine (Hannson et al., 1998). Nurr1 has been
implicated in the regulation of the expression of several of the above mentioned
important genes that are necessary for DA neurotransmission (Jankovicet al., 2005). It
has been suggested that Nurr1 regulates or coordinates the regulation of TH, DDC, DAT,
VMAT2 and GTPCH genes (Sakurada et al., 1999; Hermanson et al., 2003; Kim et al.,
2003; Gil et al., 2007). It is also needed for the continued expression of these dopamine
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neurotransmission genes (Kadkodaei et al., 2009). Nurr1 interacts with other transcription
factors and regulates the expression of TH by binding to the Nur-binding response
element (NBRE) sequence. In vitro data indicates that Nurr1 can regulate DAT and
GTPCH from NBRE independent mechanisms (Gil et al., 2007; Sacchetti et al., 2001). It
has also been reported that there is a 50 – 72% decrease in the mRNA levels of TH, DAT,
VMAT and DDC in patients with Parkinson’s disease (Deng et al., 2005).
In addition to the expression of Nurr1 in mesencephalic dopamine neurons and
regulation of dopamine neurotransmission genes, Nurr1 is expressed in a variety of
neurons throughout the brain. According to Backman et al , Nurr1 is expressed in limbic
areas, ventral midbrain and cortical areas (Backman et al., 1999). Distribution of Nurr1
mRNA using in situ hybridization demonstrated diffuse expression throughout the brain.
It is highly expressed in the cerebral cortex –including prefrontal cortex, primary and
secondary visual cortex, primary auditory cortex, secondary somatosensory cortex,
entorhinal cortex, perirhinal cortex, and dorsal endopiriform nucleus. Additionally Nurr1
is expressed in the hippocampus including pyramidal neurons in CA1, CA2 and CA3. In
the midbrain, Nurr1 is expressed in dopamine neurons in the substantia nigra pars
compacta(SNpc) and ventral tegmental area(VTA) (Zetterstrom et al. 1996; Xiao et al,
1996). It was reported by Xing et al., that there is a rapid and transient increase of Nurr1
protein expression in the granule cells of the dentate gyrus when a single
electroconvulsive seizure is administered via earclip electrodes (Xing et al., 1997). It is
also suggested that Nurr1 expression is modulated by neuronal activity and membrane
depolarization. Kainic acid induced seizures increased Nurr1 mRNA levels in the
hippocampus, cortical regions and the dentate gyrus (Crispino et al., 1998). Additionally,
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Nurr1 mRNA expression was found to be induced in dopamine neurons as a result of
increased neuronal activity (Eells et al., 2011).
Nurr1 heterozygous mice in which one gene of Nurr1 is disrupted have reduced
amount of Nurr1 expression but that does not affect the development and differentiation
of dopamine neurons (Le, Conneely et al., 1999). Nurr1 +/- mice have normal dopamine
levels in the striatum but have dopamine deficits in mesolimbic and mesocortical regions
(Eellset al., 2002, Eellset al., 2006).
Popular protein quantification methods like western blot and ELISA typically use
pieces of brain tissue to quantify the protein which makes it difficult to quantify protein
as brain tissue is not homogenous. Immunohistochemistry is a widely used technique to
study the distribution of protein, though this method achieves precise anatomical location
of interest, it is difficult to get a quantified mathematical value for the distributed protein.
Quantitative immunohistochemistry (Q-IHC) helps to locate precise anatomic location of
the Nurr1 protein expressing cells as well as get a quantitative value for the expressed
Nurr1. The main advantage is that we can identify and quantify nuclear Nurr1 protein of
individual cells. Potential observer bias is greatly reduced when specific cell regions are
being examined with Q-IHC (Matkowskyjet al., 2000) . In this study, we will be using QIHC to study the protein levels of Nurr1 in both Nurr1-null heterozygous (+/-) and wildtype (+/+)mice in subiculum, cerebral cortex which includes the somatic sensory cortex
and the primary visual cortex, the deep temporal cortex which includes the
endopeduncular nucleus and claustrum, CA1 area of the hippocampus, substanstia nigra
and ventral tegmental area .
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3.3

Materials and methods

3.3.1

Animals
The Nurr1 +/- and +/+ mice used for this study were from a colony bred at

Mississippi state university. They were maintained at 18-22°C with food and water ad
libitum. They were weaned at the age of 19-21 days and housed 3 -5 per cage.
Genotyping was done using tail DNA to differentiate between +/- and +/+ as described
previously by Castillo et al, 1998. All procedures performed on these mice were in
accordance with the National Institutes of Health Guide for the Care and Use of
Laboratory Animals, and study protocols were approved by the Institutional Animal Care
and Use Committee at Mississippi State University. The animals used in this project were
housed in the AAALAC accredited facilities of the College of Veterinary Medicine,
Mississippi State University.
Young 3 month old male +/- and +/+ mice were used for this experiment. The
mice were euthanized with CO2 asphyxiation and decapitated. The brains were removed
immediately, cut into forebrain and mid brain pieces and frozen on dry ice and then
stored at -80°C. Midbrains were used for histology and Q-IHC.
3.3.2

Histology
The midbrains were serially sectioned on a Microm HM 560 cryostat into 10μm

sections. They were mounted onto silanized RNAse free slides discarding every other
section.
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3.3.3

Immunohistochemistry
Nurr1 immunohistochemistry was used in this experiment to measure the amount

of Nurr1 protein expression in 6 different regions of the brain, and in both +/+ and+/mice. The six different regions were the subiculum, cerebral cortex, the deep temporal
cortex, CA1 area of the hippocampus, substanstia nigra and ventral tegmental area.
Different concentrations of Nurr1 antibody were also tested to ensure that Nurr1
expressing cells were adequately stained in regions of low and high expression. The
different concentrations used were 3 nM, 10nM, 30nM and 60 nM. The most ideal
concentration was then used to further study the intensity of Nurr1 expression.
3.3.3.1

Nurr1 Immunohistochemistry
Sections from the silanized slides were fixed in a 4% paraformaldehyde solution

for1hr at room temperature, and then washed 3 times in phosphate buffered saline (PBS),
and then incubated with 1%H2O2 in PBS for 30 min. Sections were washed in PBS three
times followed by blocking in 10% rabbit serum for Nurr1in PBS-BSA-Triton X100 for
45 min. Sections were then dipped in PBS once and incubated with a goat anti- Nurr1
primary antibody diluted in PBS-BSA-Triton overnight at 4°C. Sections were then
washed 5 times in PBS containing 0.1% BSA, rinsed once in PBS and incubated for 2 hrs
with biotinylated rabbit anti-goat (1:200) secondary antibody in PBS-BSA-Triton. The
sections were then washed 3 times in PBS and incubated with ABC reagent for 2 hrs
followed by washing in PBS thrice and incubating in diamino benzadine substrate
chromogen system to identify the bound antibody. Sections were counterstained with
DAPI and then coverslipped using Permount. A concentration of 20 nM Nurr1 primary
antibody was used to compare regional Nurr1 expression in Nurr1 +/- and +/- mice.
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3.3.4

Image capture
Photomicrographs of the six regions were obtained using Olympus BX51

microscope which has a fluorescent lamp and fluorescent filters with a CCD camera and
a motorized Z-stage, connected to a computer with Stereo Investigator Stereology
Software from MicroBrightField Inc. In the Stereo Investigator, the height and width of
the digital image frame are set at 268.5mm and 174.0 mm respectively for the 40x field.
Each individual region was outlined at 10x magnification. Stereo Investigator software
was used to obtain unbiased fields and digital images were acquired at 40x magnification
with an oil immersion objective.
3.3.5

Quantification of Nurr1
After procuring digital images, each Jpeg image obtained was opened in

Photoshop (Adobe, San Jose, CA). Marquee tool was used to select a 30 x 30 pixel
square in the nucleus of neurons in the images (Fig. 3.1). The Nurr1 immunoreactive
nuclei were identified and cut out using the marquee tool, then pasted and stored in a new
file in TIFF format. A region of no chromogen stain was also identified and used as a
control (Matkowskyj et al., 2000). MatLab software was used to determine the pixel
energy of the labeled nuclei using the program described by Matkowskyj et al., 2000.
3.4
3.4.1

Results
Distribution of Nurr1 protein in the brain
Initial quantitative immunohistochemistry was carried out on +/+ mice. In this

method we used immunohistochemistry to locate the anatomical region where Nurr1
protein is expressed. The software programs Adobe Photoshop and MatLab were then
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used to get a quantified mathematical value for the Nurr1 protein. Nurr1 is expressed in
the mesencephalic dopaminergic systems. It is mostly seen in SNpc of the nigrostriatal
pathway and VTA region which is connected with the mesocortical and mesolimbic
pathways. Nurr1 is also highly expressed in the limbic regions of the brains namely the
the cerebral cortex, subiculum and the pyramidal cells of the hippocampus (Fig. 3.2).
3.4.2

Titration of Nurr1 antibody
Nurr1 immunoreactivity was quantified in different regions and at different

primary antibody concentrations of 3nM, 10nM, 30 nM and 60 nM (Fig. 3.3). Nurr1
nuclei in the cortex were the most darkly stained followed by deep temporal cortex,
subiuculum then SNpc, VTA then CA1 & CA3 regions of the hippocampus. Sections that
were stained with 3 nM and 10nM antibody concentration showed Nurr1 labeling in areas
that had high expression of Nurr1 but not those regions where low expression of Nurr1
was seen. A 60 nM antibody concentration labeled Nurr1 nuclei in all the regions darkly,
however, resulted in high expressing areas becoming more similar with very little
difference from the 30 nM concentration. A primary antibody concentration of 10 and 30
nM gave the best distribution of Nurr1 intensity. Therefore, a primary antibody
concentration of 20 nM was chosen for all subsequent studies.
3.4.3

Types of Nurr1 expression
Two different types of regional Nurr1 protein distributions were observed based

on intensity. Within the cortex, 2 different populations of Nurr1 expressing nuclei were
observed based on Nurr1 intensity. Neurons in the cortex had both high expressing nuclei
as well as low to medium expressing nuclei based on the intensity of labeling and
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frequency of cells (Fig. 3.4). In contrast, the neurons in the deep temporal cortex,
subiculum, CA1 & CA3 of the hippocampus, SNpc and VTA have cells with a
homogenous expression pattern (i.e. most of the cells had similar intensity of Nurr1
expression). Additionally, within different regions there was either scattered expression
in neurons (cortex and hippocampus) or Nurr1 expression in virtually all the neurons in a
region (subiculum and deep temporal cortex). Also, in the SNpc and VTA, expression of
Nurr1 is in all dopamine neurons. Based on chromogen intensity at a 20 nM antibody
concentration, neurons in the cortex had the highest relative Nurr1 expression (100%)
followed closely by the subicullum (85%) and deep temporal cortex (76%). Lower Nurr1
levels were found in the dopamine neurons in the substantia nigra and ventral tegemental
area (39%) followed by CA1 region (25%) and CA3 region (19%) of the hippocampus.
3.4.4

Differences in Nurr1 expression across different regions between +/- and
+/+
Nurr1 nuclei in +/- mice had reduced expression of Nurr1 protein than those in

+/+. Based on chromogen intensity calculated using matlab, Nurr1 nuclei of the primary
visual cortex in +/- mice had 27% reduction of Nurr1 protein than +/-. In the deep
temporal cortex, 49% less Nurr1 protein was seen in +/- than +/+. There was 25% less
Nurr1 in subicullum,33% less in substantia nigra and 22% less in ventral tegemental area
and 21% less in CA1 region of the hippocampus in +/- than in +/+ Nurr1 mice (Fig. 3.9).
3.5

Discussion
The current study investigated the distribution and quantification of Nurr1 protein

in six different regions of the brain namely subiculum, cerebral cortex including the
somatic sensory cortex and the primary visual cortex, the temporal cortex which consists
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of theendopeduncular nucleus and claustrum, CA1 area of the hippocampus, substanstia
nigra pars compacta and ventral tegmental area using Q-IHC. Popular biochemical
immunoassays like Western blot and ELISA are the most conventionally used techniques
to study the quantification of protein. These methods mostly employ the use of tissue
homogenate or extract to detect and quantify the amount of protein, making it difficult to
use such techniques on tissue sections. Moreover, the non homogeneity of the brain tissue
makes it difficult to quantify a specific protein in a specific population of cells.
Immunohistochemistry is another widely used technique to study the distribution of
protein in tissue sections. This method very precisely enables us to study the localization
of a specific protein even at a sub-cellular level. Though widely used to detect proteins,
this technique is typically not used to quantify the amount of protein detected. We have
used Q-IHC as a method to detect the distribution of Nurr1 protein in different
anatomical locations of the brain and also as a tool to quantify the amount of Nurr1
protein in these specific populations of cells. Q-IHC utilizes the benefits of
immunohistochemistry to study the distribution of protein as well uses commonly
available software programs like Adobe photoshop and matlab to quantity the amount of
protein distributed. Using this specific method, along with stereologic methods to sample
regions, we were able to quantify the relative amount of Nurr1 protein in individual
neurons. Using this technique, it is possible to determine if individual neurons were
making more protein or if more neurons are making the Nurr1 protein in specific
populations of cells. Between +/- and +/+ Nurr1 mice, the numbers of cells that produced
Nurr1 protein were more or less similar but the amount of Nurr1 protein produced varied.
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The cortex had two different populations of Nurr1 labeled cells. Depending on the
intensity of labeling and frequency of cells, the two populations were cells with high
expression of Nurr1 and cells with low to medium expression. Role of Nurr1 in the
differentiation of midbrain dopamine neurons is well established, however, its function in
neurons in the cortex have not been determined.
When we compared +/- and +/+ Nurr1 mice, we found that the number of cells
per area were similar in density but the amount of protein produced per cell was different.
Based on the quantified mathematical value that we obtained for chromogen intensity
using Q-IHC, we determined that expression of Nurr1 protein in +/- was less when
compared to +/+. As one of the Nurr1 gene is knocked out in Nurr1 null heterozygous
mice we expected a 50% reduction on the amount of Nurr1 protein produced. There was
a 49% reduction in the amount of Nurr1 quantified in the deep temporal cortex in +/mice. In the mesencephalic dopaminergic regions namely SNpc and VTA, Nurr1proteinin
+/- was reduced by 33% and 22% respectively when compared to +/+. These data
suggest that there may be different compensatory mechanisms that can maintain Nurr1
expression in the Nurr1 +/- condition. Based on previous research, (Eells et al., 2011), it
was found that Nurr1 mRNA expression is dynamically regulated by dopamine neuron
activity. Blocking D2 receptor phosphorylates TH which increases dopamine synthesis.
Any changes in the release of dopamine alter TH phosporylation which inturn alter
dopamine synthesis. Based on the fact that Nurr1 is implicated in the regulation of TH
(Iwawaki et al 2000; Jankovic et al, 2005; Sakurada et al,1999; Hermanson et al, 2003;
Kim et al, 2003; Gil et al. 2007) we can say that Nurr1 levels function as a feedback loop
between neuron activity and regulation of gene expression. D2 receptor antagonism
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enhances Nurr1 expression while stimulation reduces expression. Based on this
hypothesis, we can say that reduced neuron activity will reduce Nurr1 mRNA expression
and vice versa. There exists a feedback mechanism that alters gene and protein
expression based on the electrical impulse of the neuron. This hypothesis can explain
why the mesencephalic regions do not show the expected 50% reduction of Nurr1 protein
in +/-.
3.6

Conclusion
These studies demonstrate the utility of using Q-IHC to measure Nurr1 protein

expression. Additionally, it appears that the Nurr1 +/- genotype reduces Nurr1 protein
expression but in a region specific way and in most regions, was considerably less than
the expected 50%. These data are important for understanding the regulation of Nurr1
protein expression and how the Nurr1 +/- genotypes affects target gene expression of
Nurr1.
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Figure 3.1

Nurr1 labeled nuclei were cut out and the pixel energy quantified using
matlab software.

Unbiased microscope fields were obtained with Stereo investigator software. Nurr1
labeled nuclei were cut out and the pixel energy quantified using matlab software. (A)
Section containing Nurr1 labeled DAB stained nuclei. (B) The stained nuclei were cut
using adobe photoshop software.
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Figure 3.2

Distribution of Nurr1 protein expression in the brain

Distribution of Nurr1 protein expression in the brain (A). It is predominantly seen in
SNPC of the nigrostriatal pathway and VTA region (B). Nurr1 is also expressed in the
limbic regions of the brains namely the cerebral cortex, subiculum, CA1 and CA2 of the
hippocampus (C).
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Figure 3.3

Nurr1 immunoreactivity in different regions of the brain.

Nurr1 immunoreactivity was quantified in different regions and at different primary
antibody concentrations. Significant differences in Nurr1 expression are shown in
different regions. Based on chromogen intensity, neurons in the cortex had the highest
relative Nurr1 expression (100%) followed closely by the subicullum (85%) and deep
temporal cortex (76%). Lower Nurr1 levels were found in the dopamine neurons in the
substantia nigra and ventral tegemental area (39%) followed by CA1 region (25%) and
CA3 region (19%) of the hippocampus. Pixel energy is the average for all nuclei
measured.
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Figure 3.4

Histogram of Nurr1 protein expression in the cortex.

The Nurr1 labeled nuclei were analyzed using the highest 50 cells with increasing
intensity.
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Figure 3.5

Histogram of Nurr1 protein expression in the subiculum.

The Nurr1 labeled nuclei were analyzed using the highest 50 cells with increasing
intensity.
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Figure 3.6

Histogram of Nurr1 protein expression in the SNpc.

The Nurr1 labeled nuclei were analyzed using the highest 50 cells with increasing
intensity.
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Figure 3.7

Histogram of Nurr1 protein expression in the VTA.

The Nurr1 labeled nuclei were analyzed using the highest 50 cells with increasing
intensity.
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Figure 3.8

Histogram of Nurr1 protein expression in the CA1 of the hippocampus.

The Nurr1 labeled nuclei were analyzed using the highest 50 cells with increasing
intensity.
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Figure 3.9

Difference in Nurr1 protein expression between heterozygous and wild
type Nurr1 mice in 6 different regions of the brain.

Based on chromogen intensity, neurons of the +/+ mice, had higher Nurr1 expression
than the +/- in the cortex (27%), subicullum (25%), deep temporal cortex (49%),
substantia nigra (33%), ventral tegemental area (22%) followed by CA1 region (21%) of
the hippocampuis.
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CHAPTER IV
EFFECT OF AGING AND NURR1 +/- GENOTYPE ON GENE EXPRESSION AND
PROTEIN EXPRESSION OF NURR1 AND OTHER ASSOCIATED DOPAMINE
NEUROTRANSMISSION GENES

4.1

Abstract
The transcription factor, Nurr1 is needed for the continued expression of

dopamine neurotransmission genes and is thought to coordinate the regulation of
expression of many dopamine neurotransmission genes. Previously it was reported that
both the Nurr1-null heterozygous genotype (+/-) and aging can alter dopamine neuron
gene expression. To assess the effects of the Nurr1 +/- genotype and aging on dopamine
neuron gene expression, laser capture microdissection was used to isolate substantia nigra
pars compacta (SNpc) and ventral tegmental area (VTA) regions as well as populations
of dopamine neurons within these two regions to study the expression of Nurr1 and
associated dopaminergic neurotransmission genes. Nurr1 protein expression in both SNpc
and VTA was studied using quantitative immunohistochemistry. In SNpc dopamine
neurons, there was a trend toward elevated Nurr1 expression in the Nurr1 +/- aged mice.
For DAT gene, the aged +/+ showed a trend towards increased expression as compared to
the young +/+ mice. In the case of the D2 receptor, there was a significant elevation in
the SNpc dopamine neurons in all groups compared to the young +/+ group. For GTPCH,
there was a significant reduction in expression in the SNpc dopamine neurons of the
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young +/- mice, as compared to the young +/+ mice. In the dopamine neurons of the
VTA, no significant differences were found for the expression of Nurr1, VMAT or DAT.
For TH, there was a significant reduction in expression in the young +/- mice and in the
aged +/+ mice, as compared to the young +/+ mice. For D2 receptor, young +/- had
significantly lower expression of D2 receptor gene when compared to other 3 groups. The
amount of Nurr1 protein present in SNpc and VTA was measured using the software
programs Adobe Photoshop and MatLab. In the VTA, the + groups had significantly
lower levels of Nurr1 protein as compared to the +/+ groups. Aging did not appear to
have any effect on Nurr1 protein expression. Both aging and the Nurr1 +/- genotype were
found to have effects on dopamine neurotransmission gene expression. There appears to
be differences in regulation of the D2 receptor between SNpc and VTA dopamine
neurons. Additionally, there appear to be compensatory mechanisms in dopamine
neurons that can maintain Nurr1 protein expression in the Nurr1 +/- genotype.
4.2

Introduction
Nurr1 is a transcription factor that plays an important role in maintaining the

dopaminergic systems of the brain. Dopamine is mostly present in the nigrostriatal
system with dopamine neuron cell bodies in the substanstia nigra pars compacta (SNpc)
which innervate the striatum, and the mesolimbic and the mesocortical system with cell
bodies in the ventral tegmental area (VTA) which innervate the nucleus accumbens and
cortex, respectively (Zetterstrom et al., 1996; Backman et al., 1999). Nurr1 is needed for
the development, differentiation and maintainence of the dopaminergic neurons
Zetterstrom et al., 1996). Nurr1 is highly expressed during the embryonic stage and its
expression remains the same in dopamine neurons throughout life (Zetterstrom et al.,
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1997). Nurr1 expression is needed for the continued expression of dopamine
neurotransmission genes such as tyrosine hydroxylase (TH), dopamine transporter(DAT),
vesicular monoamine transporter 2 (VMAT2) (Kadkodaei et al., 2009) and GTP
cyclohydrolase (GTPCH) (Gil et al., 2006). Furthermore, Nurr1 also serves as a
mechanism to coordinate the regulation of expression of many dopamine
neurotransmission genes. During normal development and differentiation of dopamine
neurons, Nurr1 is expressed at embryonic day 10.5 in the mouse (Wallen et al., 1999)
followed closely by TH at embryonic day 11.5 and later by DOPA decarboxylase (DDC),
GTPCH, VMAT2, and DAT respectively (Jaeger et al., 1986). Absence of Nurr1 arrests
the dopamine neuron precursor development and fails to express many of the genes
necessary for normal dopamine neuron function including TH, VMAT2, GTPCH and
DAT (Wallen et al., 1999; Zetterstrom et al., 1009; Castillo et al., 1998; Saucedo et al.,
1998; Wallen et al., 2001). Loss of TH, DAT and VMAT2 is seen in mature dopamine
neurons when Nurr1 is conditionally deleted (Kadkodaei et al., 2009) implicating that
Nurr1 expression is needed for the continued expression of dopamine neurotransmission
genes. Several studies have found that the Nurr1 +/- genotype impairs survival of
dopamine neurons. The neurotoxin MPTP reduces dopamine levels as well as the number
of dopamine neurons in Nurr1 +/- mice (Le et al., 1999). Additionally, dopamine
terminals in +/- mice are also more susceptible to damage by amphetamine (Syed et al.,
2005). According to Jiang et al., there was a significant reduction in dopamine neuron
numbers, straital dopamine levels and a decrease in rotorod performance in aged +/- mice
(Jiang et al., 2005). The growth of neurites was also significantly reduced in +/dopamine neurons (Eells et al., 2002). Since Nurr1 +/-/ mice have reduced Nurr1
62

expression, these mice could be useful in determining how alterations in Nurr1
expression affect dopamine neurotransmission (Madras et al., 2002).
The Nurr1 +/- genotype can influence the decline of dopamine neurons and
dopamine neurotransmission in an age dependent manner (Zhang et al., 2011). The single
most powerful risk factor for PD is aging (Chu et al., 2006). Progressive degeneration
that is seen in PD is also seen Nurr1+/- mice. They display the same biochemical,
morphological and behavioral phenotypes with age (Imam et al., 2005; Jiang et al., 2005;
Le et al., 1999a; Le et al., 1999b). According to Jiang et al., PD symptoms emerge when
age dependent decline in dopamine crosses a threshold that cannot be compensated (Jiang
et al., Jiang et al., 2005). Nurr1 +/- mice develop locomotor deficits after 15 months of
age indicating a dysfunction in dopamine neurotransmission (Jiang et al., 2005; Le et al.,
1999a). Down regulation of Nurr1 expression in SNpc is associated with age related
decline of dopamine phenotypic markers (Chu et al., 2002).
The first part of this study was to the use laser capture microdissection to isolate
SNpc and VTA regions and also dopamine neurons from SNpc and VTA regions to
study the expression of Nurr1 and associated dopaminergic neurotransmission genes in
Nurr1 +/- and +/+ mice with aging. The second part consisted of using Q-IHC to measure
Nurr1 protein expression in both SNpc and VTA of Nurr1 +/- and +/+ mice with aging.
4.3
4.3.1

Materials and Methods
Animals
The Nurr1-null heterozygous mice used for this study were obtained from a

colony bred at Mississippi State University. These mice were originally produced in the
laboratory of Dr. Vera Nikodem at the National Institute for Diabetes and Digestive and
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Kidney Diseases (Castillo et al., 1998). Mice were genotyped as previously described by
Castillo et al., 1998 to distinguish +/- and +/+ mice using tail DNA by PCR. Litters were
chosen at random for either young or aged mice. The mice were weaned at 19-21 days of
age and housed in groups of 3-5/cage. Mice were housed in cages with steel grid lids and
all cages were located in the same room. All procedures were performed in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals,
and study protocols were approved by the Institutional Animal Care and Use Committee
at Mississippi State University. All animals used in this project were housed in the
AAALAC accredited facilities of the College of Veterinary Medicine, Mississippi State
University. The individual room temperatures were maintained between 18-22°C with
food and water ad libitum. Care of the mice was overseen by a laboratory animal
veterinarian. Adult male +/- and +/+ mice, 3 months old and >15 months old mice were
used to study the gene and protein expression of Nurr1 and other dopamine related genes.
Frozen midbrain regions of wild type and heterozygous mice were serially
sectioned on the cryostat into 10µm sections. The sections were then mounted onto
RNAse free silanized and PEN membrane slides, while discarding every other section.
Dopamine neurons were isolated from SNpc and VTA regions using Laser capture
microdissection and used for gene expression. Protein expression was studied using
quantitative immunohistochemistry.
4.3.2
4.3.2.1

Gene Expression
TH immunohistochemistry for laser capture microdissection
To identify DA neurons we used rapid TH staining. All solutions were RNase-

free and the antibody solutions contained 400 U/ml of RNasin RNase inhibitor (Promega,
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Madison, WI). The sections from the PEN membrane slides were fixed in a solution
containing acetone and methanol (1:1ratio) for 10 min at -20°C, then washed in
phosphate buffered saline with 0.1% Triton-X 100 (PBS-TX). The sections were then
covered with 100 l of PBS-TX with anti-TH antibody from Chemicon diluted 1:100 for
5 min. Sections were then washed with PBS-TX, incubated 10 min with Alex Fluor 455
labeled secondary antibody (1:100) in PBS-TX, washed in PBS, dehydrated with a
graded series of ethanol which was followed by clearing with xylene and then air dried.
The slides were then visualized and isolated using the Veritas Laser Capture
Microdissection system (Molecular Devices, Sunnyvale, CA). Neurons that show TH
fluorescence in the SNpc and VTA regions (as seen in Fig. 1)were collected onto HS
capture caps as seen in Fig. 2 (Molecular Devices, Sunnyvale, CA). VTA regions were
also isolated using immunohistochemistry guided laser capture microdissection as
described in Eells et al., 2012 (Fig 4.3).
4.3.2.2

RNA analysis and Quantitative PCR
After isolating specific dopamine neurons from SNpc and VTA, RNA was

isolated using Absolutely RNA Nanoprep kits (Stratagene, LaJolla, CA). The quality of
the isolated RNA from whole sections was analyzed on the Bioanalyzer 2100 using a
RNA 6000 pico labchip and the quantity of the isolated RNA was measured using
Ribogreen assay with the Nanodrop 3300 with a standard curve of RNA concentrations to
determine the concentration of the sample RNA. RNA thus obtained was reverse
transcribed using Invitrogen Super Script III First-Strand Synthesis Super Mix, and
random hexamers and oligo dT primers. The cDNA obtained was used for quantitative
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PCR studies using Taqman primers for Nurr1, TH, GTPCH, DAT, VMAT, D2 receptor
and the housekeeping gene, β-actin with Invitrogen Platinum qPCR Super Mix. The
quantitative PCR was performed using the MX3005P QPCR System from Stratagene.
4.3.3
4.3.3.1

Protein Expression
Immunohistochemistry for Nurr1 expression
Nurr1 Immunohistochemistry was used to measure the amount of protein

expressed by Nurr1 in SNpc and VTA, in both +/+ and+/-, young and age mice. Sections
from silanized slides were fixed in a 4% paraformaldehyde solution for 1hr at room
temperature, and then washed in a phosphate buffered saline. The sections were then
covered with 1%H2O2 in PBS followed by blocking in 10% rabbit serum for Nurr1in
PBS-BSA-Tx for 45 min. This was followed by covering the sections in goat anti rabbit
Nurr1 antibody in PBS-BSA-Tx overnight. Sections were then washed with PBS-BSATX and incubated for 2 hrs with biotinylated anti goat secondary antibody in PBS-BSATX. The sections are then incubated with ABC reagent for 2 hrs followed by incubation
in DAB substrate chromogen system to identify the bound antibody. It was
counterstained with DAPI and then coverslipped using Permount.
4.3.3.2

Image capture
Photomicrographs were obtained using Olympus BX51 microscope which has a

fluorescent lamp and fluorescent filters with a CCD camera and a motorized Z-stage, all
this connected to a computer with Stereo Investigator Stereology Software from
MicroBrightField Inc. In the Stereo Investigator, the height and width of the digital image
frame was set at 268.5mm and 174.0 mm respectively for the 40x field. Each individual
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region is outlined at 10x magnification. Stereo investigator software was used to select
unbiased fields and digital images were acquired at 40x magnification with an oil
immersion objective.
4.3.3.3

Quantification of Nurr1
After procuring digital images, each Jpeg image obtained was opened in

Photoshop (Adobe, San Jose, CA). Marquee tool was used to select a 30 x 30 pixel
square in the nucleus of neurons in the images. The Nurr1 stained chromogen nuclei were
identified and cut out using the marquee tool, then pasted and stored in a new file in TIFF
format. A region of no chromogen stain is also identified and used as a control
(Matkowskyj, Schonfeld et al. 2000). MatLab software was used to determine the pixel
energy of the labeled nuclei using the program described by Matkowskyj et al., 2000 (Fig
4.9).
4.3.4

Data analysis
All the qPCR data was analyzed using the standard method. The data obtained

were statistically analyzed using ANOVA with fishers PLSD post-hoc comparison using
Statview software.
4.4
4.4.1

Results
Dopamine neurotransmission gene expression in the dopamine neurons of
SNpc and VTA
Dopamine neurons were isolated using laser capture microdissection from the

SNpc and VTA from the midbrain sections of young and aged +/+ and +/- mice. RNA
was isolated and quantitative real time PCR was done to study the expression of
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dopamine neurotransmission genes. The results for the SNpc are shown in Fig. 4.4. For
the Nurr1 gene, no differences were observed between young +/+ and +/- genotypes.
There was a trend toward elevated Nurr1 expression in the Nurr1 +/- aged mice as
compared to the aged +/+ mice (p = 0.05). Aged +/+ mice had the lowest expression of
Nurr1 mRNA. For both TH and VMAT genes, there was no significant difference across
all the four groups. For DAT gene, the aged +/+ showed a trend towards increased
expression as compared to the young +/+ mice (p=0.07). No differences between young
and aged +/- groups were found. In case of D2 receptor, there was a significant elevation
in all groups compared to the young +/+ group (p = 0.04). For GTPCH, there was a
significant reduction in the young +/-, as compared to the young +/+ group. Gene
expression results in dopamine neurons in the VTA are shown in Fig. 4.5, No significant
differences were found for the expression of Nurr1, VMAT or DAT. For TH, there was a
significant reduction in expression in the young +/- mice and in the aged +/+ mice, as
compared to the young +/+ mice (p=0.02 and 0.04, respectively). For D2 receptor, young
+/- had the lowest expression of D2 receptor gene when compared to other 3 groups. In
case of the gene GTPCH, there was a trend toward increased expression with aging
(p=0.05 as seen in Fig. 4.7). The aged +/+ mice significantly elevated expression
compared to the young +/+ mice.
4.4.2

Dopamine neurotransmission gene expression in VTA
We performed TH immunohistochemistry guided laser capture microdissection

and isolated VTA regions from midbrain sections. RNA was isolated and real time PCR
was performed to study gene expression in these samples. We measured gene expression
of TH, Nurr1 and DAT genes in these samples. No differences in expression of these
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genes were found in the VTA. The samples obtained via this method showed a high
amount of variability which might be because of non- homogenous nature of neurons that
are seen when we isolate regions instead of isolating individual neurons as shown in Fig.
4.8.
4.4.3

Nurr1 protein expression in SNpc and VTA
The amount of Nurr1 protein was quantified using quantitative

immunohistochemistry as described in Chapter 3. The amount of Nurr1 protein present in
SNpc was measured using the software programs Adobe Photoshop and MatLab as
shown in Fig. 4.9. The +/+ groups had higher levels of Nurr1 protein as compared to the
+/- groups, although was not significantly different (Fig. 4.10). Aging didn’t appear to
have any effect on Nurr1 protein expression. Results from the amount of Nurr1 protein
measured in the VTA are shown in Fig 4.11. Collectively, aged +/- genotype had a
significantly lower Nurr1 protein expression when compared to the +/- genotype
(p=0.04).
4.5

Discussion
This current study investigated the effects of Nurr1 null heterozygous genotype

and aging on dopamine neurotransmission genes in SNpc and VTA regions of the
dopaminergic system. In the first part of the study, we studied the expression of
dopamine associated neurotransmission genes in SNpc and VTA. In the second part, we
studied the expression of Nurr1 protein in the above mentioned regions using quantitative
immunohistochemistry.
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Two separate laser capture microdissection techniques were used to quantify
dopamine neurotransmission gene expression. We isolated VTA regions from midbrain
sections using immunohistochemistry guided laser capture microdissection as described
in Eells et al., 2012. Additionally, a rapid TH immunohistchemistry was use to isolate
individual dopamine neurons in both the SNpc and VTA. When the entire VTA was
isolated, there was considerably more variability in the expression of the genes measured
as compared to when individual dopamine neurons. This might be due to the nonhomogenous nature of the VTA region isolated. As these samples contained dopamine
neurons with all the surrounding glial cells from the VTA region, the variation in gene
expression could be due to this. The total levels of the gene expressed cannot be only
attributed to dopamine cells. It can also be due to expression of these genes in the
surrounding glial cells. Due to this, we isolated individual dopamine cells from SNpc and
VTA and studied further.
In the SNpc, there was a significant increase in D2 receptor expression as a result
of the +/- genotype and a trend toward reduced TH expression. Within the VTA, there
was a significant decrease in D2 receptor expression and TH expression due to the +/genotype. In chapter 2, we have seen that due to the combination of aging and +/genotype, dopamine levels were significantly reduced in the ventral striatum, specifically
in the shell and core of the nucleus accumbens. We suggest that a decrease in D2 receptor
expression could significantly reduce dopamine levels in the ventral striatum. D2
autoreceptor regulates the synthesis of dopamine (blocking D2 receptor phosphorylates
TH which increases dopamine synthesis) and dopamine neuron activity (blocking D2
receptor enhances dopamine neuron activity and dopamine release). Therefore, any
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changes in the release of dopamine can alter TH phosporylation and dopamine neuron
activity, which in turn alter dopamine synthesis and dopamine release. Alternatively,
elevated dopamine neurotransmission in the nucleus accumbens, as previously shown
with microdialysis, could alter expression of the D2 receptor in VTA dopamine neurons
(Moore et al., 2008).
Comparisons between gene expression in SNpc and VTA suggest that there are
important difference in the regulation of the expression of dopaminergic genes between
SNpc and VTA. In SNpc, there was a significant increase in D2 receptor expression and a
trend toward reduced TH expression due to +/- genotype, while in the VTA, there was a
significant decrease in D2 receptor expression and decrease TH expression due to the +/genotype. One possibility for explaining this difference can be using TH
immunohistochemistry to isolate dopamine neurons may cause bias in the populations
obtained. The dopamine neurons isolated through laser capture microdissection are the
ones that are TH positive. We might be biasing the populations of dopamine neurons as
we collect those neurons that are brightly stained with TH. Alternatively, there have been
previous reports that have found differences in D2 autoreceptor function for difference
populations of dopamine neurons (Tzschentke, 2001).
The only difference in Nurr1 mRNA expression found was an increase in aged +/mice in the SNpc. It should be noted that the probe used was located between exon 7-8 in
Nurr1, outside of where the Nurr1 sequence (Exon 3) was deleted. Therefore, Nurr1 QPCR probe recognizes both +/+ and +/- alleles. In the SNpc, +/+ groups had higher levels
of Nurr1 protein as compared to the +/- groups, however this was not statistically
significant. The elevated Nurr1 mRNA in the SNpc of the +/- mice may result from
71

compensatory mechanisms, such as increase neuron activity. This may help explain why
there was no significant reduction in Nurr1 protein in the SNpc due to either aging or the
+/- genotype. The +/+ genotype had a significantly higher Nurr1 protein expression in
the VTA when compared to the +/- genotype. Similarly, there was a reduction in Nurr1
mRNA with the +/- genotype and aging. Though there was a reduction in amount of
Nurr1 protein expressed due to +/- genotype, this was not a 50% reduction as expected
due to knockout of one gene of Nurr1 in +/- genotype. This coincided with the Nurr1
expression from different regions as described in Chapter 3.These data suggest that there
are compensatory mechanisms that may compensate for Nurr1 expression.
4.6

Conclusion
In this paper, we investigated in combination the expression of Nurr1 protein and

dopamine neurotransmission genes in the dopamine neurons of SNpc and VTA with
aging and the Nurr1 +/- genotype. Both aging and the Nurr1 +/- genotype were found to
have effects on dopamine neurotransmission gene expression. Additionally, based on
these results, there appears to be differences in regulation of the D2 receptor between
SNpc and VTA dopamine neurons. Additionally, there appear to be compensatory
mechanisms that maintain Nurr1 protein expression in the Nurr1 +/- genotype as it was
less than the expected 50% reduction.
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Figure 4.1

Photomicrograph of TH immunoreactive neurons.

Photomicrograph showing tyrosine hydroxylase immunoreactive neurons in the
substantia nigra pars compacta (SNpc) and ventral tegmental area (VTA).

Figure 4.2

Photomicrographs using the PixCell II Veritas Laser Capture
Microdissection system.

Photomicrographs using the PixCell II Veritas Laser Capture Microdissection system
showing tyrosine hydoxylase immunoreactive neurons under 10x magnification (A),
Brain Tissue after removing Dopamine neurons (B) and Captured neurons on the HS Cap
(C). These dopamine neurons were used for gene expression.
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Figure 4.3

Dopamine neurons in the ventral tegmental area after tyrosine hydroxylase
immunohistochemistry.

Dopamine neurons in the ventral tegmental area after tyrosine hydroxylase
immunohistochemistry (a). This area was used to determine the distribution of dopamine
neurons and used to dissect tissue from an adjacent section processed for laser
capturemicrodissection (b) (Eells et al., 2011).
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Figure 4.4

Dopamine neuron gene expression from dopamine neurons in SNpc.

Dopamine neuron gene expression from dopamine neurons in substantia nigra pars
compacta. (A) Nurr1 gene expression. (B) TH gene expression. (C) VMAT gene
expression. (D) DAT gene expression. (E) D2 receptor gene expression. (F) GTPCH gene
expression.
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Figure 4.5

Dopamine neuron gene expression from dopamine neurons in VTA.

Dopamine neuron gene expression from dopamine neurons in ventral tegmental area. (A)
Nurr1 gene expression. (B) TH gene expression. (C) VMAT gene expression. (D) DAT
gene expression. (E) D2 receptor gene expression. (F) GTPCH gene expression.
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Figure 4.6

Dopamine neuron gene expression in ventral tegmental area.

(A) TH gene expression. (B) Nurr1 gene expression. (C) DAT gene expression.
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Figure 4.7

Unbiased microscope fields were obtained with StereoInvestigator
software.

Nurr1 labeled nuclei were cut out and the pixel energy quantified using MatLab software.
(A) Section containing Nurr1 labelled DAB stained nuclei. (B) The stained nuclei were
cut using adobe photoshop software.

Figure 4.8

Nurr1 protein expression in SNpc.

Nurr1 protein expression in young and aged, +/+ type and +/- mice (A). Comparing the
Nurr1 protein expressed in SNpc between +/+ type and +/- genotype.
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Figure 4.9

Nurr1 protein expression in VTA.

Nurr1 protein expression in ventral tegmental area in young and aged, +/+ type and +/mice (A). Comparing the Nurr1 protein expressed in VTA between +/+ type and +/genotype.
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CHAPTER V
EFFECT OF AGING AND NURR1 GENOTYPE ON ON THE EXPRESSION OF
TYROSINE HYDROXYLASE IN DOPAMINE TARGET REGIONS

5.1

Abstract
The transcription factor Nurr1 is implicated in the regulation the expression of

tyrosine hydroxylase (TH) and other associated dopaminergic neurotransmission genes.
TH is the principal regulator in the biosynthesis of dopamine. The activity of TH is
affected by the synthesis, release and reuptake of dopamine. The absence of Nurr1, as in
Nurr1 knockout mice, blocks expression of many of the genes necessary for normal
dopamine neuron function including TH, vesicular monoamine transporter2 (VMAT2),
GTP cyclohydrolase(GTPCH) and dopamine transporter (DAT).To study the effects of
the Nurr1 +/- genotype and aging on the protein expression of TH in the shell & core of
the nucleus accumbens and the striatum, quantitative immunohistochemistry was used.
There were no quantitative differences found due to age or genotype of the mice,
however, there appeared to be visible differences in TH immunoreactivity between the
genotypes in the digital images. Therefore, the quantitative immunohistochemistry
procedures used here were not a proper method to quantify the amount of TH protein in
regions of dopamine neuron axonal innervations.
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5.2

Introduction
TH is the rate limiting enzyme in the biosynthesis of dopamine and has been

implicated to be regulated by Nurr1 in dopamine neuron development (Iwawaki et al.,
2000; Kim et al., 20003). TH catalyzes the conversion of tyrosine to L-DOPA in the
biosynthesis of dopamine. Nigrostriatal dopamine neurotransmission is regulated by the
amount of TH expressed in the SNpc neurons (Kumer et al., 1996).TH activity is affected
by factors like dopamine neuron activity, release and reuptake of dopamine, levels of
tetrahydrobipoterin and intracellular dopamine, and D2 autoreceptor sensitivity (Kumer
et al., 1996; Zigmond et al., 1989). The expression of the transcription factor Nurr1 is
followed closely by TH at embryonic day 11.5 and later by DOPA decarboxylase (DDC),
GTPCH, vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT),
respectively (Jaeger et al., 1986). Absence of Nurr1, as seen in Nurr1 knockout mice,
arrests the dopamine neuron precursor development such that these cells fail to express
many of the genes necessary for normal dopamine neuron function including TH,
VMAT2, GTPCH and DAT (Wallen et al., 1999; Zetterstrom et al., 1997; Castillo et al.,
1998; Saucedo et al., 1998; Wallen et al., 2001), indicating the role of Nurr1 in the
expression of TH. Eells et al., reported reduced expression of TH and GTPCH mRNA in
ventral midbrain of Nurr1-null heterozygous (+/-) mice using quantitative real time PCR
(2006). Mogi et al., reported that the reduction in total TH protein level by enzyme
immunoassay in the striatum was greater than that in the total enzyme activity suggesting
compensatory activation of TH in nigrostriatal dopamine neurons in the PD brain
following the reduction in the protein content (Mogi et al., 1998). Nakashima et al.,
reported a substantial decrease in TH protein levels in Parkinson’s disease (PD)
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(Nakashima et al., 2008). Development of both genetic and idiopathic forms of
schizophrenia and PD have been reported due to alterations in the activity of TH (Haavik
et al., 1998).
Since the Nurr1 knockout genotype is lethal at birth, the Nurr1 +/- mice represent
a model to test Nurr1 regulation of potential target genes. The numbers of dopamine
neurons were reported to be decreased with age in Nurr1 +/- mice (Zhang et al., 2011).
Progressive degeneration of the dopaminergic systems that is seen in PD is also seen
Nurr1+/- mice. Nurr1 +/- mice display the same biochemical, morphological and
behavioral phenotypic changes with age (Imam et al., 2005; Jiang et al., 2005; Le et al.,
1999a; Le et al., 1999b). According to Jiang et al., PD symptoms emerge when age
dependent decline in dopamine crosses a threshold that cannot be compensated (Jiang et
al., 2005). Down regulation of Nurr1 expression in substantia nigra pars compacta
(SNpc) is associated with age related decline of dopamine phenotypic markers (Chu et
al., 2002). Aging is the most powerful risk factor in the incidence of PD (Chu et al.,
2006).According to Zhang et al., Nurr +/- mice show a age dependent decline in striatal
dopamine release (Zhang et al., 2012). As Nurr1 has been implicated in regulating TH
mRNA in Nurr1 +/-, a decrease in TH protein expression dopaminergic target regions is
also expected but has not been investigated.
In this current study, we have measured the expression of TH protein in nucleus
accumbens and striatum using quantitative immunohistochemisty in young and aged
Nurr1 wild-type (+/+) and +/- mice to study the differences in the expression of TH due
to age in the dopamine target regions.
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5.3
5.3.1

Materials and Methods
Animals
The Nurr1-null heterozygous mice used for this study were obtained from a

colony bred at Mississippi State University. These mice were originally produced in the
laboratory of Dr. Vera Nikodem at the National Institute for Diabetes and Digestive and
Kidney Diseases (Castillo et al., 1998). Mice were genotyped as previously described by
Castillo et al., 1998 to distinguish +/- and +/+ mice using tail DNA by PCR. Litters were
chosen at random for either young or aged mice. The mice were weaned at 19-21 days of
age and housed in groups of 3-5/cage. Mice were housed in cages with steel grid lids and
all cages were located in the same room. All procedures were performed in accordance
with the National Institutes of Health Guide for the Care and Use of Laboratory Animals,
and study protocols were approved by the Institutional Animal Care and Use Committee
at Mississippi State University. All animals used in this project were housed in the
AAALAC accredited facilities of the College of Veterinary Medicine, Mississippi State
University. The individual room temperatures were maintained between 18-22°C with
food and water ad libitum. Care of the mice was overseen by a laboratory animal
veterinarian. Adult male +/- and +/+ mice, 3 months old and >15 months old were used to
study the gene and protein expression of Nurr1 and other dopamine related genes.
Frozen midbrain regions of +/+ and +/- mice were serially sectioned using a
cryostat into 10µm sections and mounted onto silanized slides.

83

5.3.2

Protein expression

5.3.2.1

Immunohistochemistry for TH expression
TH Immunohistochemistry was used to measure the amount of protein expressed

by TH in shell and the core of the nucleus accumbens, and the striatum, in both +/+
and+/-, young and age mice. Sections from silanized slides were fixed in a 4%
paraformaldehyde solution for 1hr at room temperature, and then washed in a phosphate
buffered saline. The sections were then covered with 1%H2O2 in PBS followed by
blocking in 4% goat serum for TH in PBS-BSA-Tx for 45 min. This was followed by
covering the sections in rabbit anti goat TH antibody in PBS-BSA-Tx overnight. Sections
were then washed with PBS-BSA-TX and incubated for 2 hrs with biotinylated anti
rabbit secondary antibody in PBS-BSA-TX. The sections are then incubated with ABC
reagent for 2 hrs followed by incubation in DAB substrate chromogen system to identify
the bound antibody. It was counterstained with DAPI and then coverslipped using
Permount.
5.3.2.2

Image capture
Photomicrographs were obtained using Olympus BX51 microscope which has a

fluorescent lamp and fluorescent filters with a CCD camera and a motorized Z-stage, all
this connected to a computer with Stereo Investigator Stereology Software from
MicroBrightField Inc.In the Stereo Investigator, the height and width of the digital image
frame was set at 268.5mm and 174.0 mm respectively for the 40x field. Each individual
region is outlined at 10x magnification.
Stereo investigator software was used to determine unbiased fields and digital
images were acquired at 40x magnification with an oil immersion objective.
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5.3.2.3

Quantification of Nurr1
After procuring digital images, each Jpeg image obtained was opened in

Photoshop (Adobe, San Jose, CA). Marquee tool was used to select a 800 x 600 pixel
square to cut the images for easier processing in MatLab, then pasted and stored in a new
file in TIFF format. A region of no chromogen stain is also identified and used as a
control (Matkowskyj et al., 2000). MatLab software was used to determine the pixel
energy of the TH stained shell and core of the nucleus accumbens, and striatum using the
program described by Matkowskyj et al., 2000.
5.3.3

Data analysis
The data obtained were statistically analyzed using ANOVA with fishers PLSD

post-hoc comparison using Statview software.
5.4

Results
The amount of TH protein was quantified using quantitative

immunohistochemistry as described in Chapter 3. The amount of TH protein present in
shell & core of the nucleus accumbens and the striatum was measured using the software
programs Adobe Photoshop and MatLab. No difference in TH protein was found due to
age or genotype in the nucleus accumbens. In the striatum, there was also no difference in
the expression of TH protein. Aging as well genotype did not have any effect on the
expression of TH as seen in Fig 5.1. Qualitatively, however, there did appear to be
greater TH expression in the +/+ as compared to the +/- mice (Fig. 5.2).
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5.5

Discussion
This current study investigated the effects of the Nurr1 +/- genotype and aging on

the protein expression of TH in the dopamine target regions of the mesencephalic
dopaminergic system. TH expression in the shell and core of the nucleus accumbens and
the striatum were measured using quantitative immunohistochemistry. No significant
quantitative differences in the expression of TH were found between the young and aged,
+/+ and +/- mice. According to Eells et al., the +/- genotype had significantly reduced
TH activity in the striatum and nucleus accumbens, when measured in vivo (Eells et al.,
2006). Quantitative immunohistochemistry results, however, did not yield any significant
differences in TH expression. Based on these results, we conclude that this method, and
the parameters used here, are not appropriate for measuring the axonal innervations of the
dopamine target regions. In this study, we acquired the images using StereoInvestigator
software, cut them into smaller images for faster processing in MatLab and measured
their pixel intensity. We did not cut the darkly stained areas as done in Chapter 3 (darkly
stained immunoreactive nuclei). In contrast to the dense, homogeneous immunoreactivty
to Nurr1 in the nucleus (see Chapter 3), TH immunoreactivity in the striatum is more
hetergenous. Since there appears to be a qualitative difference in TH immunoreactivity
between the +/+ and +/- mice in the digital images, the quantitative
immunohistochemistry technique used here is the not the best method to quantify protein
in regions with axonal innervations as compared to quantifying protein in nuclei (Chapter
3). Alternative approaches may be to use both higher magnification images and smaller
regions to obtain more homogeneous images or to use lower magnification images and
larger regions to normalize the intensity of the staining across more tissue.
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5.6

Conclusion
In this paper, we investigated the expression of TH protein in mesencephalic

dopamine neuron target regions with aging and the Nurr1 +/- genotype. Both aging and
the Nurr1 +/- genotype did not have measureable effect on TH immunoreactivity.
Differences due to genotype were qualitatively visible through digital image analysis.
Based on these results, we conclude that quantitative immunohistochemistry parameters
used may not be a proper method to quantity protein in axon innverated regions.

Figure 5.1

TH protein expression.

In young and aged, +/+ type and +/- mice. Comparing the TH protein expressed between
+/+ type and +/- genotype in core of the nucleus accumbens (A), shell of the nucleus
accumbens (B), and striatum.
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Figure 5.2

Digital image showing sections from the core of the nucleus accumbens for
TH protein expression.

In +/+ type and +/- mice. There is a visible difference in the distribution of TH stain
between +/- type (A) and +/+ (B) genotype.
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CHAPTER VI
THEORITICAL MATHEMATICAL MODEL OF A SINGLE DOPAMINERGIC
SYNAPSE FOR THE REGULATION OF DOPAMINENEUROTRANSMISSION

6.1

Abstract
Regulation of dopamine neurotransmission is controlled by dopamine synthesis,

storage, release, reuptake, and autoreceptor feedback. In this current study, we a
proposing a mathematical model at a single dopaminergic synapse to predict the changes
that occur due to change in expression of TH protein, because of aging and Nurr1 +/genotype. This model and the equations formulated will provide a framework in the
future for understanding the changes occurring at a dopaminergic synapse.
6.2

Introduction
Regulation of dopamine neurotransmission is controlled by a combination of a

variety of factors which include dopamine synthesis, storage, release, reuptake,
metabolism and autoreceptor feedback (Eells et al., 2003). Alterations in one of these
parameters, however, frequently results in compensatory changes that maintain dopamine
homeostasis.Nurr1 has been implicated in the regulation of several dopamine
neurotransmission genes including TH, DDC, DAT VMAT2 and GTPCH. TH is the rate
limiting enzyme in the biosynthesis of dopamine (Iwawaki et al., 2000). Nurr1 may
control multiple parameters that regulate dopamine neurotransmission.Therefore, it is
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informative to have a mathematical model to predict how changes in multiple parameters
alters dopamine neurotransmission. Any changes in the release of dopamine can alter TH
phosphorylation and dopamine neuron activity, which in turn alter dopamine synthesis
and dopamine release. In this current study, we were trying to see how changes in TH
expression can be predicted by use of a mathematical model to see the regulation,
synthesis and reuptake of dopamine and dopamine neuron activity in young and aged,
Nurr1 +/+ and +/- mice.
6.3

Materials and Methods
The mathematical model consists of differential equations based on rate of the

reaction. These equations were formulated based on equations from (Best et al., 2009).
The differential equations for all the reactions in are as follows
(6.1)
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The substrates are in lower case, enzyme names and velocities are in upper case
so that it is easy to distinguish between all of them. For example,
bh2, NADPH, bh4, NADP is the velocity of dihydrobiopterin reductase and it
depends on the concentration of bh2 and bh4 as well NADPH and NADP as it reduces
bh4 to bh2. All the above mentioned equations can be solved using matlab. The variables
used are gtp - Guanosine triphospahte, h2ntp – 7,8 dihydro triphosphate, bh4 –
tetrahydrobiopterin, bh2 – dihyrobiopterin, tyr – tyrosine, l-dopa – 3,4- dihydroxy
phenylalanine, cda - cystolic dopamine, vda – vesicular dopamine, eda – extracellular
dopamine, hva – homovanillic acid, tyrpool- tyrosine pool. We used the protein
expression data of TH from chapter 5 and all other parameters from already published
data.
6.4

Results
No differences were seen between the young and aged, +/+ and +/+ mice for TH

expression. As the data was inconsistent, we could not use it in the mathematical
equations.
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6.5

Discussion
In chapter 4, we suggest that a decrease in D2 receptor expression could

significantly reduce dopamine levels in the ventral striatum. D2 autoreceptor regulates
the synthesis of dopamine by phosphorylating TH which increases dopamine synthesis
and dopamine neuron activity (blocking D2 receptor enhances dopamine neuron activity
and dopamine release). Therefore, any changes in the release of dopamine can alter TH
phosporylation and dopamine neuron activity, which in turn alter dopamine synthesis and
dopamine release. Using this mathematical model, we can see how changes in the
expression of TH can play a role in dopamine synthesis, release and reuptake. As we did
not any difference in the expression of TH protein between these 4 groups, we were not
able to hypothetically predict the model.
6.6

Conclusion
Based on the concentration of TH, we will be able to theoretically calculate the

amount of dopamine synthesized and released. This model and the equations formulated
will provide a framework for understanding the changes occurring at a dopaminergic
synapse when multiple parameters are altered and how these changes interact.
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CHAPTER VII
CONCLUSION

The transcription factor Nurr1 is essential for dopamine neuron differentiation and
is important in maintaining dopamine synthesis and neurotransmission in the adult.
Nurr1-null heterozygous mice (+/-) have only one functional copy of the Nurr1 gene.
Therefore, these mice represent a condition of chronic, reduced Nurr1 expression that
does not appear to alter dopamine neuron development. These mice have been used to
investigate how reduced Nurr1 levels impact dopamine neuron function in mature,
differentiated dopamine neurons. In newborn Nurr1 +/- mice, Eells et al., found reduced
expression of TH and GTPCH in the ventral midbrain (2006b). Aging is a factor that
produces changes in the nigrostriatal dopamine neurotransmission, the mechanisms of
which are unclear. Aging in Nurr1 +/- mice represents a potentially useful model for the
study of PD and the loss of nigrostriatal dopamine functions, as this is thought to result
from a combination of genetic predisposition with environmental insults, as aging is an
important contributor to the incidence of PD. Progressive degeneration that is seen in PD
is also seen Nurr1+/- mice. They display the same biochemical, morphological and
behavioral phenotypes with age (Imam et al., 2005; Jiang et al., 2005; Le et al., 1999a; Le
et al., 1999b).
Reduced Nurr1 function due to the Nurr1 +/- genotype, impacts dopamine neuron
function in a region specific manner. Previous reports using aged Nurr1 +/- mice have
93

described significant effects in the nigrostriatal dopamine system. Aging (as early as 9-12
months) in the Nurr1 +/- mice resulted in a significant reduction in dopamine levels in the
striatum, impaired performance on the rota-rod, and reduced numbers of dopamine
neurons in the substantia nigra pars compacta in the aged +/- mice (Jiang et al., 2005;
Zhang et al., 2011). Because of the potential importance of this model, we began further
investigations into how aging alters dopamine transmission in Nurr1 +/- mice but also
included other mesencephalic dopaminergic systems. One consistent finding from these
data is that the Nurr1 +/- genotype has a greater impact on the mesoaccumbens dopamine
system as compared to the nigrostriatal dopamine system. The data from Chapter 2 found
no difference in tissue dopamine levels in the dorsal striatum of aged +/- mice. However,
significant reductions in tissue dopamine levels in the ventral striatum, including the core
and shell of the nucleus accumbens, resulted from the combination of aging and the +/genotype. To produce a stress response, we restrained the mice for 3 min prior to placing
them back in the open-field. The young +/- mice showed a significant increase in openfield activity after stress. We had previously assigned the stress induced increase in
activity to differences in mesoaccumbens dopamine neurotransmission. Based on the
present study, this difference is apparent in the absence of any detected difference in
tissue dopamine levels in the nucleus accumbens of the +/- mice, however there could be
differences in synaptic dopamine levels and dopamine neurotransmission as previously
reported (Moore et al., 2008). Although alterations in the mesoaccumbens
neurotransmission could account for differences in open-field activity in the +/-, the
precise mechanism that mediates the difference in the stress induced open-field activity in
the +/- mice is unclear.
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Although the Nurr1 +/- genotype has been found to have significant effects on the
nigrostriatal dopamine system, effects on the mesoaccumbens dopamine system appear to
be more prominent although less well characterized. Significant reductions in tissue
dopamine levels were reported in the +/- mice in the nucleus accumbens without
significant effects in the striatum (Eells et al., 2002b; Eells et al., 2006b). In the current
data, no significant differences in dopamine levels in the ventral striatum of young +/mice were observed, either in the shell or core of the nucleus accumbens. Aging may be
an important variable in producing the deficit in tissue dopamine levels in the ventral
striatum. The difference in tissue dopamine levels observed may also be due to local
effects across the dorsal and ventral striatum or due to anatomical or physiological
differences of neurons innervating these areas.
To further investigate the effects of the Nurr1 +/- genotype and aging on
dopamine neuron function, laser capture microdissection was used to isolate substantia
nigra pars compact (SNpc) and ventral tegmental area (VTA) regions as well as
populations of dopamine neurons within these two regions to study the expression of
Nurr1 and associated dopaminergic neurotransmission genes. Nurr1 protein expression in
both SNpc and VTA was also studied using quantitative immunohistochemistry (Chapter
4). Although significant effects due to the +/- genotype were observed in the nigrostriatal
dopamine system, more effects were seen in the mesoaccumbens dopamine system. In the
SNpc, there was a significant increase in D2 receptor expression as a result of the +/genotype and a trend toward reduced TH expression. Within the VTA, there was a
significant decrease in D2 receptor expression and TH expression due to +/- genotype. In
Chapter 2, we have seen that due to the combination of aging and +/- genotype, dopamine
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levels were significantly reduced in the ventral striatum, specifically in the shell and core
of the nucleus accumbens. We suggest that a decrease in D2 receptor expression could
significantly reduce dopamine levels in the ventral striatum. D2 autoreceptor regulates
the synthesis of dopamine (blocking D2 receptor phosphorylates TH which increases
dopamine synthesis) and dopamine neuron activity (blocking D2 receptor enhances
dopamine neuron activity and dopamine release). Therefore, any changes in the release of
dopamine can alter TH phosporylation and dopamine neuron activity, which in turn can
alter dopamine synthesis, storage and release.
In addition to dopamine neurotransmission genes, Nurr1 mRNA and protein
levels were also measured as a result of aging and the +/- genotype. The only difference
in Nurr1 mRNA expression found was an increase in aged +/- mice in the SNpc. It should
be noted that the probe used was located between exon 7-8 in Nurr1, outside of where the
Nurr1 sequence (Exon 3) was deleted. Therefore, Nurr1 Q-PCR probe recognizes both
+/+ and +/- alleles. Nurr1 mRNA levels, across these groups were not reproduced by the
quantitative immunohistochemistry. In the SNpc, +/+ groups had higher levels of Nurr1
protein as compared to the +/- groups, however this was not statistically significant. The
+/- genotype had a significantly lower Nurr1 protein expression in the VTA when
compared to the +/+ genotype. Similarly, there was a reduction in Nurr1 mRNA with the
+/- genotype and aging, however was not statistically significant. These data again
suggest a greater effect of Nurr1 expression in mesoaccumbens dopamine neurons.
Additionally, though there was a reduction in amount of Nurr1 protein expressed due to
+/- genotype, this was not a 50% reduction as expected due to knockout of one gene of
Nurr1 in +/- genotype. This coincided with the Nurr1 expression from different brain
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regions as described in Chapter 3, where only an approximately 20-30% reduction in
Nurr1 expression was observed. These data suggest that there are compensatory
mechanisms that can maintain Nurr1 protein expression closer to the +/+ level.
Although Nurr1 is implicated in the regulation the expression of TH and other
associated dopaminergic neurotransmission genes mRNA expression, to understand the
effects on dopamine neurotransmission requires determining effects on protein levels. TH
is the principal regulator in the biosynthesis of dopamine and the activity of TH is
affected by the synthesis, release and reuptake of dopamine. To investigate the effects of
the Nurr1 +/- genotype and aging on dopamine regulation, the protein expression of TH
in the shell & core of the nucleus accumbens and the striatum was measured using
quantitative immunohistochemistry. There were no differences between the aged and
young, +/+ and +/- mice. There appeared to be visible differences in the stained regions
between both the genotypes in the digital images. Therefore, the current quantitative
immunohistochemistry methods did not appear to be appropriate method to measure TH
protein in target regions of axonal innervations.
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